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Abstract
Localization of mRNA in the cell plays a vital role in functioning of the cell, especially in development
and neuronal plasticity. The aim of this thesis was to generate a new RNA labeling system using FRET
between fluorescent proteins. Short specific RNA sequences, called aptamers, were used to bring the
fluorescent proteins in close proximity to observe FRET. To achieve this, the aptamer binding peptide,
λN22 , was inserted at various sites in the donor (EGFP and mTFP1) and acceptor (mKO2 and mKO3)
fluorescent proteins. This provided the advantage of tethering the λN22 tagged fluorescent proteins at
different angles on this specific aptamer, the boxB RNA. The idea was to investigate which FRET pair
would offer the best FRET efficiency when the peptides bind to the RNA. Depending on the structural
conformation the RNA adopts in solution, different distances and orientation between the donor and
acceptors would form, which would help to compare the FRET efficiency of different FRET pairs .
The first step towards this approach was generation of mKO2 acceptor proteins which have the λN22
peptide inserted in different tolerant sites in the middle of mKO2 protein. Using the Tn5 transposon
system acceptor proteins were generated offering a range of orientational specificity on binding the
boxB RNA. Generation of acceptors tagged with λN22 either at N- or C-terminal was done using
a mutant form of mKO2 generated in the lab, termed as mKO3. mKO3 is a modified version of
mKO2, generated in the lab, where the C-terminus of mKO2 is mutated to introduce last 9 amino
acids from Aequorea GFP C-terminus thus making mKO3 more tolerant to C-terminus labelling in
comparison to mKO2. When these acceptor proteins were brought in close proximity with the donors
(also tagged with λN22) on binding a 5boxB sequence in vitro, a small and unspecific FRET ratio
change was observed. Along with FRET change, unspecific quenching of emission intensity also
occured. The mKO2-λN22 / mKO3-λN22 variants show unspecific FRET ratio change with the λN22
tagged EGFP / mTFP1 donor proteins. With increase in the concentration of RNA, there was a change
in the DR/R values, but the direction of this change differed for different FRET pairs and not related
to aptamer binding. This thesis was able to show a FRET ratio change between λN22 donor and
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acceptor fluorescent proteins on binding the aptamer. Depending on the conformational change in the
aptamer on binding the λN22 peptide certain orientations of the donors and acceptors might be more
suitable for FRET to happen, compared to others. This finding might pave the way for a new RNA
tagging method, with more extensive and defined work this could be used to label and monitor mRNA
in the cytoplasm and therefore reduce the need of a nuclear localization signal to compartmentalize
the unbound fluorescently labeled RNA binding protein in the nucleus.
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Chapter 1
Introduction
1.1 The central dogma of molecular biology
Life is said to be a contrast between randomness and determinism. The chaotic interaction of bio-
molecules gives rise to a precise coordination in a living organism and that always seems to be a won-
der [1]. A living organism is composed of cells which are in turn formed by a number of biomolecules.
These biomolecules cooperate with each other, at different levels either intra-cellular or inter-cellular,
in a very precise manner to give rise to every action, thought, or function performed by that living
organism. Lack of, or improper functioning at one of the levels, leads to a disorder or diseased con-
dition. The main biomolecules forming a living organism are DNA (deoxy-ribonucleic acids), RNA
(ribo-nucleic acids), proteins, carbohydrates and lipids. Present in the central compartment of a eu-
karyotic cell, the nucleus, it is responsible for storing and encoding the genetic information required
for normal functioning of the cell and also the response under stress. DNA encodes into the func-
tional and structural players of the cell, proteins. Proteins are the main machinery of the cell, as they
function as enzymes, form part of the cytoskeleton, the motor machinery like actin and myosin, the
receptors on the extra-cellular surface, the channels that let ions and nutrients diffuse through the cell
membrane into the cell.
The DNA is not directly encoded to form the protein. It is first transcribed into a messenger RNA
(mRNA). The nucleotide sequence in the mRNA determines the amino acid sequence of a protein.
Many functional RNAs are needed to get protein from DNA sequences. Eukaryotes express many
non-protein-coding RNAs (ncRNAs) that participate in the processing of other RNAs and also in
their regulation. The modern RNA world, as we know it, does not consist of just the RNAs involved
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in protein synthesis like mRNA, tRNA, rRNA. And it is not a simple process of transformation of
DNA to mRNA to protein, but a network of RNA infrastructure is involved. How they interact and
connect spatially and temporally, we are still in the process of discovering. As a result, focus of
research has shifted from more protein-centric to more genomics.
1.1.1 The RNA world
Interestingly, only 2.3% of the human genome is encoded into a mRNA [2], although not all the
genome is transcribed into protein. Therefore a huge part is non-protein-coding and is sometimes
referred to as the dark matter of the cell [3]. The dark matter or the non-coding genome of the cells
consists of various small non-protein coding RNAs (ncRNAs), which despite their nature and small
size widely influence protein induction, translation silencing, transport and various other functions
in the cell via cleavage, nucleotide modifications, transcription and destruction. The whole RNA
infrastructure of the cell includes: mRNA (messenger RNA), tRNA (transfer RNA), rRNA (ribosomal
RNA), miRNA (micro RNA), snRNA (small nuclear RNA), snoRNA (small nucleolar RNA), long
ncRNA (Long non-protein coding RNA), piRNA (PIWI-interacting RNA), riboswitches.
1.1.1.1 miRNA (micro-RNA)
MicroRNAs were discovered in 1993 by Victor Ambors, Rosalind Lee and Rhonda Feinbaum during
a study of the gene lin-14 in C. elegans development [4]. In 2000 a second RNA was discovered,
let-7, that lead to a dramatic change in how gene regulation happens in the cell [5]. Animal miRNAs
regulate translation by down-regulation of translation via mRNA cleavage or deadenylation of poly-A
tail. Within miRNAs there is another category of regulatory RNAs, the siRNA, which down-regulate
expression by degrading the mRNA .
1.1.1.2 snRNA (small nuclear RNA) /snoRNA (small nucleolar RNA)
snRNAs bind to small proteins to form snRNPs which are involved in pre-mRNA splicing. snRNAs
undergo the cleavage during mRNA splicing [6]. The splicing of pre-RNA yield snoRNAs which are
then involved in rRNA splicing. This is one of the examples of how RNAs interact in the cell and
influence the overall function of the cell.
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1.1.1.3 piRNA (PIWI-interacting RNA)
piRNAs bind to the Piwi family of proteins (PIWI, Argonaute 3, Aubergine) and were discovered
initially in Drosophila and mammal germline cells [7]. They are known to be involved in transposon
defense in Drosophila ovaries.
The above are the RNA regulating RNAs.
The following three RNAs form the core of the RNA infrastructure in the cell:
1.1.1.4 rRNA(ribosomal RNA)
rRNAs form the core of the ribosomes on which the mRNA is translated. rRNAs provide a mechanism
of peptidyl transferase activity for mRNA decoding into amino acids by interacting with the tRNAs
during protein translation. Then the tRNA brings the correct amino acid corresponding to the mRNA
codon. The 18S rRNA in most eukaryotes is in the small ribosomal subunit, and the large subunit
contains three rRNA species (the 5S, 5.8S and 28S rRNAs). rRNA is the most conserved gene in all
cells [8].
rRNA transcripts 18S, 5.8S and 28S are generated in the nucleolus by RNA Pol I. They are also
formed first as pre-rRNA and then undergo processing to form rRNA. They are important for the
ribosomal assembly formation for protein translation. The processing of pre-rRNAs is guided by
snoRNAs which are found in the introns of mRNA and released on proper splicing of mRNAs [9].
1.1.1.5 tRNA (transfer RNA)
tRNAs are adaptor molecules that recognize and bind the triplet codon on the mRNA on one side
and an amino acid on the other side. tRNAs are transcribed in the nucleus and undergo modification
and splicing in the nucleus. The codon on the mRNA cannot directly recognize the amino acid they
specify by the combination of 3 nucleotides. There is when the tRNAs come into picture. They
traverse along the length of the mRNA when it is being translated and transfer the appropriate amino
acid as per the codon. There are a number of tRNAs synthesized by the cell and the identification
of the correct amino acid for the right tRNA is by the help of aminoacyl-tRNA synthetases. The
combined action of synthetases and tRNA leads to the correct association of the amino acid on the
mRNA codon for synthesis of polypeptide chain, linking amino acids together [8].
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1.1.1.6 mRNA(messenger RNA)
mRNAs are the first known form of RNA. They are encoded from the DNA sequence in the form of
pre-mRNA. This pre-mRNA form has the presence of protein coding regions, called exons, and pro-
tein non-coding regions, called introns. The pre-mRNA is spliced, introns are removed and depending
on the splicing pattern or splice sites on the pre-mRNA, isoforms of the protein can be obtained. The
mRNAs are spliced by an exon-junction complex, and a number of other spliceosomes and proteins
are involved [10]. Their processing has an important significance on the RNA infrastructure of the cell
as the snoRNA are found within the introns of rRNA. After splicing the mature mRNA is transported
out of the nucleus via the nucleopores, into the cytoplasm for translation into a protein.
Subsequent chapters will deal in more detail about the importance of mRNA transport on spatial and
temporal protein expression in the cell.
1.1.2 Regulatory conformational changes in RNA
After the discovery of the various different classes of RNA, it became evident that RNA is not just
a target of post-transcriptional genetic regulation. ncRNAs in prokaryotes and eukaryotes function
as trans-acting regulators of gene expression. However, recently a new mode of RNA-mediated
regulation of gene expression has been uncovered where the mRNA itself serves as the modulator.
The mRNA can regulate its transcription, processing and translation by undergoing a conformational
change promoted by direct binding with a cellular metabolite or ligand. Such cis-acting RNA se-
quences, called Riboswitches, are found abundantly in prokaryotes and in a few eukaryotes. Such
riboswitches are mostly found as regulators of a cellular metabolic pathway. It is considered as the
simplest mode of regulation of gene translation in bacteria.
Riboswitches are usually found on the 5’ UTR of the mRNA . They are part of the feedback mecha-
nism in prokaryotes where binding of a small metabolite, such as cofactors, or temperature can change
the tertiary structure of the RNA and either inhibit or up-regulate translation of the mRNA [11]. Later,
“RNA thermometers” were found. They have a highly structured 5’UTR that covers the ribosome
binding site under normal temperatures. Once it senses the selected temperature, it undergoes a con-
formational change and exposes the Shine-Dalgarno (SD) sequence, facilitating ribosome bindings
and initiating translation. Recently a Mg2+ metal sensing riboswitch , called the M-box, was also
discovered.
Riboswitches are generally formed of two parts: the aptamer, where the metabolite binds; and the
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expression-platformwhich undergoes the conformational change on aptamer binding the ligand (metabo-
lite), and thus regulates the expression of the gene downstream. The conformational change of the
riboswitch is usually in the form of an alternative hairpin structure, which leads to occlusion or ex-
posure of ribosome binding sites thereby forming or disrupting transcriptional terminators or anti-
terminators. The various metabolites riboflavin-, cyanocobalamine-, thiamine-, bind to their respec-
tive riboswitches FMN-box, B12-box, THI-box (translation termination).
Thiamine riboswitch
Thiamine riboswitch (THI-box) is the only riboswitch which is found in all three kingdoms: it has
been found in many bacteria, archea, algae, fungi and in plants. In bacteria, the THI-box causes
translation inhibition and premature transcription termination. In fungi and algae, it controls mRNA
splicing [12]. In plants it is postulated to be involved in processing or mRNA stability [13]. Since the
cellular levels of TPP is low, the cell carefully regulates the TPP production to meet biological need
by regulating the gene expression of the enzymes involved in TPP production. THI-box is present
in the intron of 5’-UTR in fungi (e.g. Aspergilius oryzase, Neurospoa crassa) and in the 3’-UTR in
plants (Arabidopsis thaliana).
Structurally THI-box consists of five helices, P1-P5. They are arranged in two parallel helical struc-
tures: P2, bluge J3-2, P3, loop L3, form one helical structure; P4, bulge J4-5, P5, loop L5, form a
second helical structure. They are both connected to helix P1 and thus the whole structure represents
a tuning fork [14]. Helix P2/J3-2/P3/L3 bind the pyrimidine moiety and helix P4/J4-5/P5/L5 bind the
phosphate group of TPP. When TPP is bound it is completely buried in the RNA, sitting perpendicular
to the two helices. In presence of Mg2+ (1mM physiological concentration) the affinity of THI-box
for TPP is shown to increase by 50 fold [15]. The E. coli THI box, called thiM, forms the helices P4
and P5 only on binding to the TPP as they base pair with parts of the expression domain to form a
long helix. This leads to the anti-SD sequence becoming unpaired and binding to the SD sequence
which then leads to the inhibition of translation [16].
1.2 RNA localization and trafficking
Since the discovery of ncRNAs, there is a need to understand how these players of the same family
interact with each other to achieve the proper functioning of the cell. RNA processing is strongly
13
Figure 1.1: thiM riboswitch structure model in the absence (left) and presence (right) of TPP. Nu-
cleotides that form stem structures or loops in the TPP-bound state are color-coded. The nucleotides
representing the SD region are depicted in green and the anti-SD region is colored in light orange
[16].
14
interconnected, especially how the different components move through the cell during maturation and
RNA processing. As seen from the chapter above, RNAs are processed and regulated by other RNA
molecules and a network of interactions exist between different RNA classes. A good example of
that is the gene expression, from transcription to translation, a process which involves processing of
3 major RNAs, the rRNA, tRNA and mRNA. rRNA is processed by RNaseMRP and snoRNAs, the
tRNA by RNaseP and the pre-mRNA by snRNA which are present in the spliceosomes. Another
good example is the regulation of mRNA by miRNA or siRNA so that translation happens only when
the correct stimulus is received by the cell, which is a very important feature for neuronal cells. To
understand how RNA processing works, i.e. transcription, translation, splicing, silencing, it is needed
to have a mechanistic view of how RNA moves in the cell during each process, to gain an integrated
view of eukaryotic cellular biology [9] RNA tagging and detection in vivo is important to understand
how mRNAs are transported to specific sites in the cell and also how different RNAs interact with
each other.
Observed in Ascidian eggs almost 20 years ago, RNA localization is now considered to be a very
essential cellular process governing gene expression in eukaryotic cells. Intracellular mRNA local-
ization is a common mechanism to achieve asymmetric distribution of proteins [17].
1.2.1 Advantages of mRNA localization
mRNA localization is a very important mechanism for the cell and has many advantages. Firstly it
allows gene expression to be spatially restricted in the cytoplasm. Secondly, it gives high temporal
resolution to protein expression as a local stimuli can initiate on-site translation of the mRNA. Thirdly,
the cell saves energy and resources as it does not have to translate mRNA at one site and transport each
protein individually to each site. With mRNA transport, localized mRNAs can be translated multiple
times to generate many copies of the protein at the required site itself. Lastly, the local translation of
proteins protects the cell from some toxic or deleterious proteins, as they are translated only at the
site of action and maybe excised out of the cell.
1.2.2 mRNA localization in different organisms
Almost 70% of the mRNA in Drosophila embryo has been observed to have asymmetrical distri-
bution [18]. The cellular distribution of maternal mRNAs plays an important role in patterning and
15
Figure 1.2: Examples of asymmetrically localized mRNA, (A) Drosophila oocytes, (B) Egg of a
cindarian, Clytia, (C) Aplysia sensory neuron, (D) Drosophila embryo, (E) Cultured mammalian
fibroblasts, (F) Xenopus axonal growth cone.
Christine E .Holt et al. Science, Vol.326 #1212, 2009
establishing of dorso-ventral and anterio-posterior body axes in Drosophila [19]. In Xenopus they are
found to be important for germline development and patterning of the mesoderm and endoderm [20].
In yeast, Saccharomyces cerevisiae, actomyosin-dependent mRNA trafficking participates in polar
growth, asymmetric cell division, targeting of membrane proteins and import of mitochondrial pro-
teins [21]. The best example is transport of ASH1mRNA to the bud tip of a dividing cell. This ensures
that the mRNA is delivered only in the nucleus of the daughter cell. This was also the system in which
for the first time, in 1998, Bertrand et al. [22] reported the first glimpse of live cell mRNA trafficking.
They inserted MS2phage binding sites in the ASH1 mRNA and labeled the MS2 coat protein with
GFP and described ASH1 movement in the cell (mechanism described in subsequent chapters).This
was the launch pad for in vivo detection of mRNA monitoring in a number of organisms. Recently,
Zipor et al. have reported the use of the MS2 phage system to study the localization of peroxiso-
mal protein encoding mRNAs in Saccharomyces [23]. mRNA trafficking has also been observed in
16
Candida albicans and Ustilago maydis, and seems to be universally important for polar growth of
fungi.
RNA targeting is also shown to be an essential process for plant growth and development. mRNA
transport and localization is emerging as an important mechanism to control protein targeting, deter-
mining cell fate and polar cell growth as well as RNA silencing in plants [24].
1.3 mRNA transport in neurons
One of the most remarkable functions of mRNA transport appears to be in the neuronal cells. Neu-
ronal process often extends great distances from the soma. For rapid local response to stimuli and for
undergoing change in synaptic strength and structure it is necessary that the protein is translated then
and there at the site of stimulation or at the growth cone of the axons in developing brains where the
β-actin mRNA has been seen in abundance for stimulant changes in growth in streeing [25]. Activity
dependent synaptic changes are required for memory formation and storage in the brain [26], and the
models for that are LTP (long-term potentiation) and LTD (long-term depression) [27]. It has now
become evident that protein translation is required for the late phase of LTP and intermediate stages
of LTD are dependent on new protein translation which is independent of transcription. RNA-binding
proteins target specific mRNAs to the synapse. Depending on the stimulus received at the synapse
only the right kind of protein is translated and used, proteins that are not used are present in a re-
pressed phase of translation. In hippocampal neurons, strong synaptic activation is accompanied by
rapid transcription and transport of Arc mRNA to the activated synapse [28]. The Arc protein is im-
plicated in the endocytosis of AMPA receptors to maintain synaptic homeostatis [29]. This has been a
very important mRNA for studying the rapid induction and transport to the activated synapse for mon-
itoring mRNA transport in the neurons. Guwoski etal. conducted enrichment learning experiments on
mice followed by a catFISH assay to study how different neurons are stimulated by different stimuli
based on this unique feature of Arc. Study of sensorin mRNA in Aplysia shows that not only mRNA
localization to the synapse is important, but also newly synthesized Sensorin protein affects synaptic
properties, depicting that newly synthesized protein could have different properties from older protein
copies. One of the common functional protein mRNAs that localize to the cellular processes in the
neurons is CREB (cAMP response element-binding) protein. It can be translated locally in the axons
in response to nerve growth factor and undergoes retrograde transport to the nucleus where it acti-
vates transcription of target genes [20]. Defective transport of mRNA to the synaptic sites has been
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shown to cause a number of disease like conditions, e.g. Fragile X Mental Retardation, which is due
to improper binding and transport of mRNA by FMRP (fragile X mental retardation protein).
For dendritic targeting of mRNAs, the sequence carrying their destination address is usually encoded
in the 3´-UTR. Shortly after transcription and splicing, the newly formed mRNA is bound by RNA-
binding proteins at its 3´-UTR before it comes out of the nucleus. It is also attached by hnRNPs
(heterologous nuclear ribonucleoproteins) in the nucleus, which have been shown to shuttle out with
the RNA and then shuttle back in the nucleus once their cargo has been delivered. As soon as the
RNA comes out of the cytoplasm it is bound by other RNA binding proteins, ribosomes, RNA he-
licases, protein translation machinery (e.g eIF4), motor proteins and small ncRNAs that keep the
mRNA translation repressed or stalled till the mRNA reaches its target site, or receives the correct
stimulus for translation as in some dendritic proteins. Thus the mRNA does not travel unattended,
but accompanied by a whole set of proteins and this whole complex is called a Ribonucleoprotein
particle (RNP). The RNPs travel rapidly, at a rate of 0.1µm/s, bidirectionally and with support of the
microtubules or kinesin. Once the RNPs reach the target destination, and receive the right stimulus,
the translation machinery is activated, the hnRNPs are sent back to the nucleus and the mRNA is
translated into a protein.
Understanding the dynamics of mRNA transport, the specificity of its localization, the spatial and
temporal aspects of transport are vital. For this, visualizing the mRNA in live cells is important.
1.4 Methods to detect RNA in cells
Sensitivity and precision in RNA detection and tagging methods is very important for determining the
functioning of a cell and understanding the diseased states. There are a number of diseases linked to
defects in expression or functioning of the RNA [30, 31], also miRNA’s function has been implicated
in cancer biology, fragile X syndrome, schizophrenia, which makes it important for us to detect RNA
expression and study its transport and functioning in the cell. Also, in the recent years studying the
transport of mRNA has been a very interesting and exciting subject. The finding that IEGs (Immediate
Early Genes) e.g. c-fos, Arc; are rapidly expressed in the neurons on stimulation and some of them
are transported to the sites of synaptic plasticity as a ribonucleoparticle (RNP) to be translated. This
has necessitated the study about which IEGs are expressed by which neurons on what stimulus and
the sites of stimulation to where the RNP translocates.
The initial methods to study RNA expression in a given population on cells was done by cell disrup-
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tion, extraction on total cellular RNA and its analysis in vitro to quantify RNA, like semi-quantitative
PCR. The other methods are Northern Blotting, separating cellular RNA by size, microarray, and
serial analysis of gene expression for high throughput detection of many RNAs at once. The major
disadvantage of the above mentioned methods is that these involve extraction of RNA from the cell
and subsequen analyzation. Therefore, it is not possible to determine when the RNA is transcribed
and how, and where it transports into the cell. But this information is important in order to understand
malfunction in the cells due to latency in gene expression or due to non-directed transport of the RNP
e.g.defects of oocyte development if the RNA is not transported to the polar region. To overcome
these problems, newer methods were designed to understand the temporal and spatial behavior of
RNA in the cell. These methods include fluorescence in situ hybridization (FISH) where exogenous
short oligonucleotide probes carrying a fluorophore tag are used to bind to a specific sequence on the
targeted cellular RNA. A modification of this method is the catFISH [32]. catFISH allows temporal
and spatial quantification of a neuronal population which have been activated by two distinct stimuli,
thereby a separate set of animals for quantification by each stimuli is not required. The above methods
though label the RNA in the cells, do cause disruption of the cell membranes because of the chemicals
used to introduce the oligoprobes and secondary labels inside the cells; the cells must be fixed and
excessive washing is required to wash off the unlabeled probes which otherwise leads to false signal.
Other methods include ’Quenched probes‘, Molecular beacons, dual FRET probes, and quantum
dots to label the endogenous RNA and track its localization or study RNA dynamics. A cartoon
representation of various methods to study RNA localization is given in figure 1.3 . The disadvantage
here is that these methods also involve disruption of the cell membrane to introduce the probes in
the cell [33]. Other methods include selection of RNA apatamers which bind a fluorescent dye and
this binding causes increase in the fluorescence signal of the dye, called ’light up‘ method, and such
aptamer-fluoroden complex is sometimes called ‘light-up pairs’. A number of such light up probes
for RNA detection have been developed like Malachite green (shown in 1.4), nonspecific dye thiazole
orange (TO) which binds to small molecules such as GMP and AMP. But the drawback of this dye is
that it binds to endogenous GMP and AMP. To work with this method, generation of an RNA aptamer
that binds specifically to the dye is necessary. That aptamer should then be fused to the gene of
interest. The aptamer size is also quite small and is advantageous. A number of groups are working
on dyes like Sulforhodamine B, Dimethyl Indole Red (DIR), but work needs to be done to make them
work in vivo so that the dyes are not toxic to the cell and can penetrate the cell without disrupting the
membrane, plus increasing the number of dyes with which we can monitor more than one RNA at a
time or RNA-RNA interactions [33].
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Figure 1.3: Schematic representation of different fluorogenic probes for detection of mRNAs. Donor
(green), quencher (gray) and acceptor (yellow) dyes are attached to the probes and interact as indi-
cated.
Sanjay Tyagi, Nature Methods, Vol.6 #5, May 2009
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(a) (b)
Figure 1.4: Malachite green binds to mRNA and makes it fluorescent. (a) Chemical Structure of
Malachite Green, it is non fluorescent because of the phenyl rings that rotate like a propeller and
dissipate the energy that the dye absorbs from light. (b) Schematic representation of an mRNA with
aptamer motifs bound to Malachite green in the UTR.
Sanjay Tyagi, Nature Methods, Vol.6 #5, May 2009
1.5 Use of bacteriophage RNA binding peptides for mRNA tag-
ging
Monitoring RNA transport and kinetics in live cells would be much easier if fluorescent RNA tags
existed that could be directly cloned into the RNA of interest. But the lack of such fluorescent RNA
tags necessitated the development and use of a different approach to study RNA transport in vivo. This
approach involved the use of two recombinant molecules. First one is a hybrid RNAwhere the mRNA
of interest is fused to a RNA binding sequence specific to an RNA-binding protein (RBP) and the
second is the RNA-binding protein fused in-frame to an easily readable protein (mostly a fluorescent
protein). When these two constructs are co-expressed in a cell, the fluorescently tagged RBP should
be tethered to the exogenous mRNA via the cognate RNA sequence. This tethering approach allows
to monitor the RNA in live cells since a functional read-out protein is fused with the RBP. In some
cases this approach is used to study the functional domains of a RBP. An ideal RBP should bind with
great affinity and specificity to its cognate RNA (among the many other RNA sequences in the cell)
and should not be naturally found in the cells used for RNA imaging. Since the success of using
GFP based fluorophores for protein detection in vivo, their use has been adapted for RNA detection
in vivo [34]. To achieve the purpose of imaging RNA, multiple copies of the phage hair-pin motif
21
(a) (b)
Figure 1.5: mRNA imaging with GFP tagged RBPs. (a) Schematic representation of MS2 phage coat
protein-GFP based tagging. A number of MS2 coat proteins bind to cognate RNA sequence which
is introduced in the 3´UTR of the target mRNA. Since each MS2 coat protein carries a GFP tag,
it makes the mRNA more fluorescent than the surrounding. (b) Fluorescence image of a fibroblast
expressing MS2 coat protein-GFP and an mRNA containing a RAB13 UTR, and 24 copies of MS2
phage hairpin.
Sanjay Tyagi, Nature Methods, Vol.6 #5, May 2009
are cloned in the UTR of the mRNA under study. And this mRNA, along with the RBP fused with
a fluorescent protein reporter, are co-expressed in the cell. Upon binding of the fluorescently tagged
RBP on the RNA motif, the mRNA is rendered fluorescent and thus can be imaged in the live cell.
Since GFP tagged RBP is always fluorescent, GFP bound to mRNA needs to be differentiated from
unbound GFP. This was achieved by introducing a nuclear localization signal to the GFP-fused RBP,
so that the unbound RBP-GFP resided in the nucleus and only on being bound to the mRNA it comes
out in the cytoplasm to be imaged. The advantages offered by this method are that it allows kinetic
studies of RNA turnover, transport and interactions as two different RBPs can be used at the same
time to label two different RNAs and there is no need to perturb the cellular membrane to introduce
the probe in the cell. This approach is used in many laboratories for studying mRNA localization in
live cells and two most widely used proteins are of bacteriophage origin: MS2 phage coat protein and
1-22 peptide of Lambda N protein. A cartoon representation of RNA tagging and monitoring using
bacterophage system is shown in figure 1.5 .
In 1998 Bertran et al. used MS2 phage coat protein for studying ASH1 mRNA localization in yeast
cells. MS2 coat protein binds to a unique RNA hair pin structure towards which it has a strong affinity.
The MS2 phage coat protein is 129 amino acids and it binds as a dimer to a 19 nucleotide long stem-
loop structure. At higher concentrations, the MS2 coat protein dimerises. It was also observed that on
increasing the number of binding sites for the MS2 coat protein, the binding affinity is not increased
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but causes a decrease in the steady state level of the reporter mRNA. The MS2 phage is not affected
by the nucleotides in the stem region of the RNA. The reasons for more number of studied using MS2
phage coat protein for tethering over the λN22 peptide can therefore be purely historical [35].
The λN system was recently discovered as an alternative to the MS2 phage system. It binds with
tight affinity and specificity to its cognate RNA sequence boxB. The development of λ phage in
E.coli depends on the positive control of genes transcribed by promoters pR and pL, which in turn are
regulated by two operon specific antiterminator proteins cro and N, respectively. The N antiterminator
activates the early operons and the cro antiterminator activates the late operon. These proteins function
by binding to RNA polymerase (RNAP) during early phase of transcription and block its response
downstream. The N protein is an RNA binding protein that requires a specific RNA sequence in the
transcribed RNA for binding.
The N protein requires a nut site for its action. The nut site functions in the form of an RNA, it binds
N protein, then undergoes RNA looping and delivers N protein to RNAP thus facilitating interaction
between N protein and RNAP. The interesting discovery here is that the nut site contains two impor-
tant domains: boxA and boxB. boxA is 8-12 bp, and 5-10 bp downstream of it is the 15 bp boxB
domain. boxB is an interrupted palindrome which can fold into a hairpin (stem-loop) structure. boxA
is a conserved sequence and is recognized by N proteins of related ‘lambdoid’ phages. But boxB’s
sequence varies from phage to phage and is recognized only by its cognate N antiterminator protein
and binds to it [36].
1.5.1 Binding of the λN peptide to boxB
The λN peptide interacts with boxB site via its arginine-rich domain. Studies on a number of RNA-
binding proteins like ribosomal proteins, the coat protein from RNA viruses, the human immunode-
ficiency virus (HIV) Tat and Rev proteins and the bovine immunodeficiency virus Tat protein show
that they have a similar RNA binding structure. It consists of one arginine rich motif, as short as ap-
proximately 8-20 amino acids in length. Tan and Frankel, in 1995, showed via extensive mutagenesis
and CD spectroscopy that the λN (1 – 22 amino acids) peptide consists of an arginine rich domain and
displays 35% α-helical conformation. The isolated peptide largely displays a random coil structure,
but the bound peptide shows and α-helical content of 80%. Mutations like Glu Pro, at position 9
eliminated the α-helical conformation and bound their cognate RNA with very poor affinity [37].
Binding of the protein to the RNA is accompanied by structural rearrangement of the RNA struc-
ture, like nonstandard base pairing and stacking plus changes in groove dimensions. The λN peptide
23
(a) (b)
Figure 1.6: Alignment of arginine-rich N sequences in phages l (Franklin 1985b; Chattapadhyay
et al. 1995b (a) Consensus boxB hairpin in phage l showing specific pattern of base-pairing and base-
flipping (purines 7 and 9) (b). Three sites of peptide-base contact (Su et al. 1997) are as indicated. The
open box indicates a sheared GA base pair; the black box highlights the position of contact with Ala-3
in the major groove. The RNase footprint of the N protein (Chattapadhyay et al. 1995a) is shown
at left; the proposed allosteric surface involved in binding to the core antitermination complex is
shown at right. (R) The proposed interaction of the flipped base (R9) with NusA in an antitermination
complex is indicated.
Su L et al. Genes Dev. 1997; 11:2214-2226
recognizes both the stem and loop region nucleotides for effective binding. The boxB of λ phage
is 15 nucleotides long, a palindrome hairpin structure which contains a purine rich pentaloop. As
discussed above that the N protein binding to the nut site of the RNA leads to RNA looping and forms
a functional bridge between the N protein and the RNAP (as shown in figure 1.6 ). Su et al. in 1997,
showed that the asymmetrical binding of the arginine rich domain of the λN peptide to one side of
the RNA leads to the re-structuring of the other via base-paring, stacking and flipping. This structural
change is strongly required for it’s biological activity, as boxB binds NusA only once it is bound to N
protein and its conformation changes. The unbound boxB consists of a stem and a flexible loop with
stable base pairing and base-stacking. Once the λN peptide binds to the boxB, the 5’-G and the 3’-A
form a sheared base pair. Over this are stacked purine and pyrimidine bases (or displaced), leading to
the formation of a GNRA tetraloop. This tetraloop structure requires the indole-base stacking which
is provided by the Trp-18 of the λN peptide. Trp-18 forms a direct stacking with the A7 purine of
the RNA and this stabilizes the tetraloop, which stabilizes the G-A sheared base thereby leading to
the looped conformation that is needed for the N-protein RNAP interaction, as shown in figure 1.7.
Change of base from A to U decrease the stacking with the TRp-18[38].
Austin, et al. in 2002 showed that the λN22 peptide binds with picomolar affinity to their cognate
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Figure 1.7: (A) The N protein binds to an RNA enhancer element in the nascent message (nut site;
asterisk indicates boxB RNA hairpin) and to host factors and RNAP to direct formation of a proces-
sive antitermination complex. (B) Closing base pair (U5 and A11) and purine-rich pentaloop (bases
6–10; underlined) of 15-basenutL boxB(5´-GCCCUGAAGAAGGGC-3´), with numbering scheme as
shown. Red-outlined box (Trp-18) and nucleoside position (7) indicate site of indole–adenine stack-
ing; blue nucleosides (7–10) exhibit a specific pattern of base-pairing (A10), -stacking (asterisk), and
flipping (G9). Black rectangles indicate stacking between closing base pair (UA) and GA sheared
base pair. Bidirectional arrows indicate NOEs between purines; base 9 is “flipped out.” Peptide–RNA
contacts (such as A7–Trp-18) were identified by isotope-filtered NMR experiments designed to re-
solve NOEs between 13C- or15N-attached protons in a labeled peptide and 12C- or 14N-attached
protons in the unlabeled RNA .
Su L et al. Genes Dev. 1997; 11:2214-2226
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Figure 1.8: Structural model of λN22-lboxB. The second base in lboxB (in Grey) loop stacks with
Trp18 of λN22 (in red) in the cognate complexes.
Ryan J.Austin, etal. JACS, 124, 10966-10967, 2002
RNA hairpin at physiological salt concentrations [39]. The structural model of λN22-boxB binding is
shown in figure 1.8.
These studies lead to the use of λN22 peptide as an RNA tethering protein to study RNA-protein
interactions and mRNA transport. Initially the λN peptide was used by De Gregorio et al., in 1999,
with just 1 boxB site; later 5 boxB sites were used for effective binding and tethering by Nathalie
Daigle and Jan Ellenberg to study mRNA transport via β-actin zip code. The boxB insertion sites
also varied from the 5’-UTR to the inter-cistronic region, the 3’-UTR, to just before the stop codon,
with 3’-UTR region being the most common RNA insertion site. λN peptide’s RNA binding property
has been used to analyze protein function for Agronulate 1 & 2 in HeLa cells [40, 41]; for studying
mRNA transport via β-actin zip code in NRK cells [42]; for studying the translation in Xenopus
oocytes by injecting the oocytes with the in vitro transcribed mRNA [43].
The recent advantage is that with the development and use of λN22, it has provided an opportunity
to image two mRNA species simultaneously, e.g. monitoring of ASH1 mRNA by λN22, and IST2
mRNA by MS2 phage done in yeast by S. Lange et al. [17].
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(a)
(b)
(c)
Figure 1.9: Schematic representation of the GFP-based tagging with λN22. (a) Expression plasmids
encoding RNA fused to 4XboxB (left), and the RNA reporter protein, a fusion of 4XλN22, 3XmEGFP
and M9 nuclear localization sequence (NLS). Arrow shows binding of λN22 peptide to the RNA hair-
pin. (b,c) Test plasmid, RNA product and cartoon representation of expected sub-cellular localization
of mRNA and encoded protein for an mRNA exported from the nucleus and localized to the cell lead-
ing edge (b) and targeted to the ER (c). Expression driven by pCMV promoter.
Daigel & Ellenberg, Nature Methods, Vol.4, No.8, 2007
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1.6 Tn5 transposon system
Transposons are mobile DNA sequence found in prokaryotic and eukaryotic genomes. Transposons
have long been used for randomly distributing primer binding sites, creating knockouts, and introduc-
tion of genetic tag into long DNA sequences. One of the most commonly used transposon systems is
Tn5 which was isolated from gram negative bacteria.
Tn5 consists of two inverted, almost identical sequences called IS50L and IS50R that encompass
genes coding for resistance for kanamycin, bleomycin and streptomycin. Tn5 transposition mecha-
nism occurs through ’cut and paste‘ method. The transposon is excised from its site on the donor
DNA and inserted into target DNA sequence. This activity is executed by enzyme Transposase (Tnp)
which is encoded by IS50R. No host proteins are required for this action. Tnp first identifies and
binds to the ES (End Sequences) within a compacted DNA polymer. The ES are inverted 19 bp DNA
sequences at the termini of IS50 in order to catalyze transposition. The Tnp forms a complex with
the two ES-bound Tnps thus forming a scaffold for enzymatic catalysis. The DNA cleavage occurs
that releases the ES sequence at each end of the donor DNA. The cleaved Tnp-ES DNA complex is
then bound to the target DNA as the DNA cleavage from the donor results in displacement of donor
DNA. Tnp then catalyses the insertion of ES DNA into the target DNA via nucleophilic attacks by
two 3´OH groups on either side of a 9 bp target DNA. In the end, the Tnp complexes with ES and
target DNA are released and the 9 base pair gaps on either side of the inserted Tn5 sequence are filled
by the host cell machinery.
The transposon Tn5 has been modified for commercial use and has 1000 fold higher transposition
efficiency than a wild type Tn5 system.
1.7 Fluorescence
Fluorescence is known to be a process of luminescence describing an electronic system that is excited
by absorbing light of a certain wavelength and relaxed by releasing light with a higher wavelength.
Molecules having the ability to undergo fluorescence are called fluorophores, those that only absorb
light without being able to emit light are named chromophores.
A fluorophore can absorb one photon of a certain energy or several photons with equivalent summed
energy (time slot for several photons: 10−15 s), leading to the transition of an electron from ground
state to an excited singlet state. Precondition for absorption is parallelism of transition dipole moment
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of the molecule with the photon’s electric field component oscillation plane.
Fluorescence lifetime
The average time a fluorophore stays in its excited state is called fluorescence lifetime τ . It is typ-
ically in the range of some nanoseconds and shows a single exponential decay for most fluorescent
molecules:
I(t) = I0e−
t
τ
Every fluorophore has a characteristic fluorescence lifetime that is dependent on environment condi-
tions and can be quenched by oxygen or nearby fluorophores. Thus it can be measured to estimate
energy transfer (FRET) that is described in the next section.
Stokes shift
After absorbing a photon, some of the gained energy will be internally converted to heat. Thus,
the emitted photon will have a longer wavelength (shifted to red spectrum) - the offset of emitted
wavelength to excitation wavelength is called Stokes shift. It is as well as the fluorescence lifetime
characteristic for each fluorophore and also shows a dependence on environment conditions.
Quantum yield
Another important characteristic of fluorophores is the quantum yield, also called quantum efficiency,
describing the chance of emitting a photon from the excited state:
QY = Nemitted
Nabsorbed
where Nemitted is the number of emitted photons and Nabsorbed is the number of absorbed photons. A
quantum yield of 1.0 (equals 100%) implies that all excited molecules release a photon when relaxing
to the ground state. There is no dependence of the quantum yield on the wavelength of a fluorophore.
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Extinction coefficient
Based on the Beer-Lambert law, absorbance of electromagnetic radiation passing through a substance
of molar concentration and 1 cm thickness is defined by the molar extinction coefficient ε:
ε = E
c·d ; E = log10
I0
I
where E is the extinction (decrease of initial intensity), c is the concentration and d is the film thick-
ness in a cuevette. ε is dependent on temperature and wavelength and can easily be determined by a
photometer with the common unit of measurement l mol−1cm−1.
Intrinsic brightness
As a measure for comparison of optical properties among different fluorophores, the intrinsic bright-
ness is introduced as the product of quantum yield and extinction coefficient. The unit of measurement
is l mol−1cm−1.
1.8 FÖRSTER resonance energy transfer (FRET)
1.8.1 Principle of FRET
FÖRSTER resonance energy transfer, named after Theodor Förster, is the physical process of radia-
tionless energy transfer from a donor molecule to an acceptor molecule. In relation to fluorescence
measurement methods the donor or both, donor (D) and acceptor (A) must be fluorophores.
This powerful technique can be applied as a sensor method on molecular level to monitor amongst
others (see figure 1.10 on the facing page):
• cleavage
• interactions of molecules
• proteolysis
• protein modifications
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(a) Protein – protein interaction: FRET
occurs by complex formation of the tar-
get proteins
(b) Proteolysis: FRET stops with pro-
tein degradation
(c) Conformational change: FRET oc-
curs after posttranslational modifica-
tions etc.
Figure 1.10: Typical applications of FÖRSTER resonance energy transfer (FRET) with fused fluores-
cent proteins. D and A refer to the donor and acceptor, respectively
Kees Jalink, Netherlands Cancer Institute (NKI-AVL)
• conformational changes
The ratio of the number of energy transfers to the number of donor excitations is defined as FRET
efficiency E:
E = Nenergy transfers
Ndonor excitations
It also reflects the resonance energy transfer rate in a ratio to the sum of the donor emission rate,
energy transfer rate and the radiationless decay rate:
E = kET
kf+kET+
∑
ki
Three major preconditions must be fulfilled in order to achieve a high rate of radiationless energy
transfers:
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1. Spectral overlap:
The donor emission spectrum must overlap with the acceptor excitation spectrum (see fig-
ure 1.11)
Figure 1.11: Spectral overlap of donor emission and acceptor absorption: emitted photons from the
donor are within the wavelength range of the acceptor. Nevertheless, the energy from donor to accep-
tor is transferred radiationless.
Author: Maurel Damien
2. Distance of donor and acceptor:
At a certain distance between donor and acceptor, called FÖRSTER radius R0, the FRET effi-
ciency reaches 50%. It is of utmost importance to control the distance r, which is in the range
of 1 – 10 nm, as it affects the FRET efficiency by the sixth power:
EFRET = R
6
o
R60+r6
where r is the distance of the FRET pair.
3. Orientation:
Donor and Acceptor should have parallel or close to parallel oscillation planes. The energy
transfer rate and the 6th power of FÖRSTER-Distance R0 are proportional to κ2:
kET , R0 ∼ κ2
Values of κ2 are in the range of 0 to 4, where 0 describes orthogonality of donor and acceptor,
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whereas 4 indicates parallel and collinear orientation. For measurement of FRET with freely
diffusing donor and acceptor molecules, e.g. in a fluorescence spectrometer cuevette, κ2 equals
2/3. If two fluorescent proteins that are suitable for FRET are fused intra-molecular, controlling
the orientation of both is especially important. Thus, changes in FRET efficiency can originate
from conformational or orientation variations.
1.8.2 Measurement of FRET
1.8.2.1 Only donor is fluorescent
Energy transfer from donor to acceptor can be measured with a fluorescence spectrometer or a fluo-
rescence microscope using different methods:
• measurement of donor emission
Resonance energy transfer leads to a decreased intensity of donor emission. Thus, measurement
of donor emission in presence (IDA) and absence (ID) of the acceptor can give quantitative re-
sults for FRET efficiency:
EFRET = 1− IDAID
• measurement of fluorescence lifetime
The characteristic fluorescence lifetime of the donor fluorophore can be quenched by energy
transfer or local environment:
EFRET = 1− τDAτD
Measurement approaches are time domain or frequency domain based.
1.8.2.2 Donor and acceptor are fluorescent
The ratio of donor intensity to acceptor intensity can provide a measure for energy transfer, but due
to the strong dependence on intensity and fluorophore concentrations, this approach requires complex
data acquisition and processing.
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1.8.2.3 Design rules of fluorescent proteins for FRET
Design and improvement of FPs for FRET experiments should focus on maximizing the FRET ef-
ficiency E and the intensity ratio of donor and acceptor (R=IA/ID). Additionally, a good FRET pair
reveals conformational changes or bindings by providing an adequate change in FRET efficiency
(∆E) and accordingly a robust change in ∆R/Rmin.
1.9 Fluorescent proteins
Fluorescent proteins (FPs) are proteins that emit fluorescence light of a certain wavelength range in
the visible spectrum when exposed to light with shorter wavelength. They are of invaluable relevance
for modern cell biology as the can be fused to other proteins of interest to function as markers or
biosensors, as they are less toxic then chemical dyes when excited by fluorescence light. Another
major advantage over synthetic dyes, that need to be manually introduced in the cells, FPs can be
expressed by intracellular transcriptional and translational machinery and do not require external
cofactors except oxygen to find the final conformation [44]. Due to the fluorescence of FPs it is
possible to record time and space distribution of the fused protein in living cells, organs and whole
organisms. Most of engineered FPs to be used in biology labs are based on the discovery of the green
fluorescent protein.
1.9.1 History
In the 1960s and 1970s Osamu Shimomura [45] first purified the green fluorescent protein (GFP)
from the jellyfish Aequorea victoria. It took then another two decades until Douglas Prasher achieved
cloning and sequencing of wtGFP in 1992 [46]. The lab of Martin Chalfie published expression
of wtGFP in E. coli and C. elegans in 1994 [47] with some minor changes in the sequence. The
experiments showed, that this near-wtGFP folded and was fluorescent at room temperature, without
the need for exogenous cofactors specific to the jellyfish. But wtGFP had several drawbacks, including
dual peaked excitation spectra, pH sensitivity, chloride sensitivity, poor fluorescence quantum yield,
poor photostability and poor folding at 37°C.
The crystal structure of GFP was first reported independently in 1996 by the Remington group [48]
and the Phillips group [49]. Solving the crystal structure was important for understanding the chro-
mophore formation and interactions of neighboring residues.
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1.9.2 Structure and properties
(a) wholly-reproduced pro-
tein
(b) cutaway version to show
the fluorophore
Figure 1.12: Green Fluorescent Protein drawn in cartoon style with fluorophore highlighted as ball-
and-stick
A fluorescent protein consists of a few amino acids forming a small chromophore which is encased
in a 11-stranded β-barrel structure of ~ 27 kDa [46, 50] (figure 1.12). The GFP from A. victoria has
a major excitation peak at a wavelength of 395 nm and a minor one at 470 nm. Its emission peak is
at 509 nm which is in the lower green portion of the visible spectrum [51]. Its physical and chemical
properties are dependent on environment conditions (pH value, temperature) and on the composition
of amino acids. The emission of wild-type GFP for example is quenched by acidic pH values with an
apparent pKa near 4.5, whereas excitation efficiency is slightly shifted from the main excitation peak
at 395 nm to the subsidiary peak at 470 nm [50]. Oxygen is only required for maturation of GFP and
does not seem to effect the fluorescence properties. High GFP concentrations amplify excitation peak
at 395 nm at the expense of the peak at 470 nm [51]. Table 1.1 shows fluorescence properties of the
commonly used enhanced GFP (EGFP) from CLONTECH. Changes in the sequence can emerge the
development of dedicated FPs for specific applications, e.g FRET (see 1.8).
1.9.3 GFP derivatives
The wide range of applications (see 1.9.4) as well as the negative properties of wtGFP (see 1.9.1)
triggered the development of derivatives with improved spectral characteristics, like fluorescence in-
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tensity, photostability, and excitation and emission wavelengths matching those of common filter sets.
The lab of Ole Thastrup [52] discovered enhanced GFP (EGFP), a point mutation leading to an in-
creased folding efficiency at 37 °C, opening GFP to applications in mammalian cells.
Many color mutants have been designed, including blue fluorescent protein (EBFP, Azurite etc.), cyan
fluorescent protein (ECFP, Cerulean, CyPet), yellow fluorescent protein (YFP, Citrine, Venus, YPet),
orange fluorescent protein (mOrange, mKO, mKO2) and red fluorescent protein (mCherry, tdTomato),
see figure 1.13. Derivatives of CFP and YFP are often employed for FRET experiments (see 1.8).
Inserting peptides at specific sites in FPs and employing circular permutation FP variants have lead
to empirically improved response of FRET-based sensor constructs, leading to increased intensity
ratio of donor and acceptor or optimization of orientation between donor and acceptor chromophores.
Especially FRET based Ca2+ indicators benefit from optimization, resulting in increased dynamic
range upon binding of Ca2+, maximized FRET efficiency E intensity ratio of donor and acceptor
(R=IA/ID). They are chimeric proteins composed of a short-wavelength variant of GFP, calmodulin
(CaM), a glycylglycine linker, the CaM-binding peptide of myosin light-chain kinase (M13), and a
long-wavelength variant of GFP [53].
Figure 1.13: A San Diego beach scene drawn with an eight color palette of bacterial colonies ex-
pressing fluorescent proteins derived from GFP and the red-fluorescent coral protein dsRed. The
colors include BFP, mTFP1, Emerald, Citrine, mOrange, mApple, mCherry and mGrape. Artwork by
Nathan Shaner, photography by Paul Steinbach, created in the lab of Roger Tsien in 2006
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mKO2 and mTFP1
The mKO is derived from CoralHue Kusabira-Orange (KO), which was cloned from the stony coral,
whose Japanese name is Kusabira-ishi. Wild-type CoralHue KO forms a brightly fluorescent dimer
and has been carefully engineered to form mKO that maintains the brilliance and pH stability of the
parent protein. Recently, a fast-folding mutant of mKO named monomeric Kusabira orange 2 (mKO2)
was introduced [54]. The monomeric Kusabira orange 2 mKO2 construct was provided by Atsushi
Mikawaki (Brain Science Institute RIKEN, Japan). It shows an absorption maximum at 551 nm, a
maximum emission at 565 nm and is very photostable.
The plasmid encoding the monomeric teal fluorescent protein (mTFP), was provided by Robert E.
Campbell (University of Alberta, Edmonton, Canada). A study [55] showed that mTFP has many
advantages, such as a high quantum yield and improved brightness and photostability. The peak
excitation of mTFP is at 462 nm and peak emission is at 492 nm. mTFP is already known to be a good
FRET donor for mKO2 as both mTFP and mKO2 are very photostable. mKO2 emission spectral
overlap with mTFP emission spectrum is less than the overlap of yellow FPs with mTFP, and the
excitation percentage of mKO2 at 458 nm (excitation wavelength of mTFP) is just 4.3% which helps
to reduce acceptor spectral bleedthrough thus making them an excellent pair for detecting varying
separation distances by measuring FRET efficiencies [55] (figure 1.14). Table 1.1 shows spectral
properties of mTFP and mKO2.
FP Peak
excitation
Peak
emission
Quantum
yield
Extinction
coefficient
(×10−3M−1cm−1)
Intrinsic
brightness (see
1.7)
mTFP1 462 492 0.85 64 54
mKO2 551 565 0.62 63.8 53
EGFP
(CLONTECH)
488 507 0.60 55 34
Table 1.1: The characteristics of mTFP and mKO2
Yuansheng Sun and Cynthia F. Booker and Sangeeta Kumari and Richard N. Day and Mike David-
son and Ammasi Periasamy, Characterization of an orange acceptor fluorescent protein for sensi-
tized spectral fluorescence resonance energy transfer microscopy using a white-light laser, Journal of
Biomedical Optics (2009), S. 054009
EGFP is used as a FRET donor the excitation of mKO2 is at 550 nm and should perform well as FRET
acceptors when paired with EGFP. In my work I used a directed evolution of mTFP, called mTFP1,
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Figure 1.14: Excitation and emission spectra of mTFP and mKO2
Yuansheng Sun and Cynthia F. Booker and Sangeeta Kumari and Richard N. Day and Mike David-
son and Ammasi Periasamy, Characterization of an orange acceptor fluorescent protein for sensi-
tized spectral fluorescence resonance energy transfer microscopy using a white-light laser, Journal of
Biomedical Optics (2009), S. 054009
which has the same spectral properties but slightly higher photostability than mTFP [56].
1.9.4 Applications
The easy expression of FPs in cells together with being not or much less phototoxic compared to
chemical dyes has initiated a revolution of fluorescence microscopy and thus has changed the use
of this technique in different biological fields. Long-term experiments with highly automated mi-
croscopes enable the study of growth of cells, signaling and transport events to the point of observ-
ing development of whole embryos of small specimens like Caenorhabditis elegans or Drosophila
melanogaster. FP based biosensors can act as passive fluorophores, showing insensitivity to environ-
mental changes. Active FP biosensors are designed to change fluorescence properties (e.g. emission
wavelength or intensity) dependent on environment conditions. Thus, they can act as sensors for Ca2+
and FRET sensors (section 1.8) [57]. Last but not least, photokinetic experiments like fluorescence
recovery after photobleaching (FRAP) and photoactivation are group of important applications for
FPs. Both approaches reveal mobility properties of FP-tagged proteins by either bleaching (FRAP)
the fused FP or activating its fluorescence from the dark state (photoactivation) and recording the
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recovering signal or intensity distribution, respectively. The latter one is also used for localization
microscopy (PALM [58], STORM [59]) to produce superresolution images.
1.10 Aim of the thesis
The aim of this study was to generate a method of labeling and detecting mRNA transport in cells
using FRET. In eukaryotic cells there has been increased interest in the recent years to study mRNA
movement as targeted mRNA transport leads to localized translation of specific proteins involved
in embryonic development, synaptic plasticity in neurons, yeast budding; and also faculty mRNA
transport has been implicated in diseases like Fragile X Syndrome. The tagging and monitoring of
mRNA has, therefore, been a field of great interest. Monitoring transport of RNA in live cells is a
challenge undertaken by many labs. Most recently the method used to achieve this using a phage
system like MS2 or λN22, where a fluorescent reporter is tagged to a RNA binding protein and the
cognate binding site for the RBP is inserted in the RNA of interest under study. But there have been
many drawbacks to using these strategies. The first system designed for this purpose was the MS2
system and was developed in the yeast cell system and there are some difficulties in optimizing it for
the mammalian cells. Also, the use of MS2 or λN22 system involves that the RBP-fluorescent reporter
is confined in the nuclear compartment till the RNA is expressed and carries the RBP-fluorescent
reporter tethered to it into the cytoplasm and eventually the site of RNA localization. But if the
nuclear localization signal (NLS) on the RBP is not compatible to the cell system or not very stringent,
then the RBP-fluorescent reporter might diffuse out of the nucleus leading to false signals. Or the
expression patterns of the RNA and the RBP are not synchronous leading to the degradation of the
RNA even before the expression of RBP. Since this varies for the system from cell type to cell type, it
employs a lot of effort to optimize the system for a specific cell type. A similar situation we observed
while trying to study the riboswitch action of thiM using FRET, we had no fluorescent signal out of
the nucleus in co-transfected cells, implying the need for a better, more uniform system of labeling
RNA. Therefore, we wanted to design a method of monitoring mRNA transport by circumventing the
problems of leaky NLS sequences, by using FRET.
This should notify the binding of the RBP-fluorescent proteins on the RNA and thus the RNA transport
can be monitored. Also, once the RNA is discharged or degraded the FRET should be reversed. The
first step to achieve the above was to see FRET change in a cell free system, in vitro, as a proof of the
binding of the RBP-fluorescent proteins on the RNA sequence and thereby to confirm the functionality
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of the system.
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Chapter 2
Materials and methods
2.1 Molecular biology
2.1.1 DNA restriction digestion
The restriction sites on vectors consist of a short sequence that usually comes along in a palindromic
manner and have a length of 6/8 bp. These sites can be recognized by a specialized restriction en-
donuclease that breaks the double strand and often leaves a single stranded (sticky) end. Restriction
of DNA was used to prepare the vector backbone/PCR fragment for subsequent cloning or to analyze
a given DNA for the correct introduction of a desired DNA-fragment after ligation. Control digests
for checking the successful incorporation of a DNA stretch was done with 1 - 2µl (100 – 200 ng) of
DNA.
After incubation for one hour at 37 °C, the digestion samples were then run on an Agarose gel at 75V
for one hour for the bands to separate and check for DNA fragments of various sizes.
Preparative digests for subsequent cloning were performed as follows:
2 - 10 µl DNA (2-10 µg)
BSA (bovine serum albumin 100 x, NEB) 0.5 µl
Restriction buffer for restriction enzyme (10
x, NEB) 5 µl
Restriction enzyme ( 10 U) 1 - 3 µl
H2O To make total volume upto 50 µl
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Incubate for 3 h – 16 h at 37 °C (dependent on the restriction enzymes that were used and on the
manufacturer’s advice [NEB]).
2.1.2 Ligation of DNA fragments
To introduce a new stretch of DNA into a vector backbone it is necessary to place different restriction
sites at each end of the desired DNA. Treatment of the vector backbone and the DNA of choice with
the same set of restriction enzymes enables the directed introduction of the desired fragment into the
vector backbone. The molar ratio of vector to insert should be 1 : 3 to 1 : 5. Amount of DNA to be
used was determined by a NANODROP spectrophotometer (NANODROP TECHNOLOGIES) to measure
DNA amount.
Vector DNA ( 50 ng) 0.5 - 1 µl
Insert (dependent of the size and concentration) 1 - 3 µl
T4 ligase buffer (10 x) 1.5 µl
T4 DNA ligase (300 U) 1 µl
H2O To make total volume to 20 µl
After incubation for one hour at room temperature, the samples were transformed with 2µl E. coli
XL blue chemically competent cells.
2.1.3 Polymerase chain reaction (PCR)
Originally developed by Kary Mullis, this method allows the amplification of a distinct strand of
DNA. For that purpose one makes use of a thermal-stable variant of DNA polymerase. This can be
Taq (Thermus aquaticus), Vent (Thermococcus litoralis) or Pfu (Pyrococcus furiosus). The different
enzymes vary in speed and accuracy of amplifying DNA. Pfu polymerase is known to have a high
proof-reading capacity and is the choice for subsequent cloning.
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PCR-reaction mix 50 µl (final volume)
DNA template 0.5- 1µl (depending on DNA concentra-
tion
Forward primer 0.5 µl (50 µM)
Reverse primer 0.5 µl (50 µM)
Herculase Polymerase buffer (10X) 10 µl
dNTP solution 1 µl (12.5 mM)
H2O 36 µl
Pfu Polymerase 0.8 µl ( 2 U)
Addition of DMSO to the reaction mix often enhances the yield of DNA obtained by the PCR espe-
cially when the reaction initially produces too little DNA.
Reaction cycle for 1 λN22:
1. 95°C − 5 min
2. 95°C − 30 seconds
3. 57°C − 30 seconds
4. 72°C − 30sec
5. Repeat steps 2 X 30 Cycles
6. 72°C − 5min
7. incubate at 4°C
Reaction cycle for mTFP1/EGFP/mKO3:
1. 95°C − 5 min
2. 95°C − 30 seconds
3. 57°C − 1 min
4. 72°C − 1min
5. Repeat steps 2X 30Cycles
6. 72°C − 5min
7. incubate at 4°C
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Reaction cycle for T75boxBSp6:
1. 95°C − 2 min
2. 95°C − 20 seconds
3. 55°C − 2 seconds
4. 72°C − 30sec
5. Repeat steps 2X 29 Cycles
6. 72°C − 3min
7. incubate at 4°C
PCR-reaction mix was prepared in an ice block and put into thermal-cycler which was pre-heated to
a temperature of 95 °C.
2.1.4 λN22 insertions in mKO2 using transposon Tn5
To achieve the idea of different orientations of mKO2, FRET pair acceptor, when bound on the RNA
I needed to obtain mKO2 variants with λN22 insertion at different sites in mKO2. For this purpose
transposons were used. The transposon Tn5 has been modified for commercial use and has 1000 fold
higher transposition efficiency than a wild type Tn5 system. Any sequence contained between the
19 bp ES sequence will be transposed into the target DNA sequence. This feature is made use of by
the EZ-Tn5™ In-Frame Linker Insertion kit from EPICENTRE.
By using this Tn5 system NotI restriction enzyme sites were introduced into mKO2 target sequence
contained in pRSETB plasmid by Anselm Geiger in the lab. After the insertion reactions the clones
were selected on kanamycin-containing plates to identify and screen the transposed clones. After the
determination of insertion of the transposon site by PCR and restriction digestion, the clones were
digested by NotI restriction enzyme and the linearized segments were purified and re-ligated. The re-
ligation gave a single NotI site and 57 nucleotide insertion in the target mKO2, 9 of these nucleotides
are the 9 bp sequence duplication on either side of the transposon site. The colonies were selected on
ampicilin-containing plates
2.1.5 Transformation of chemically-competent E. coli
Chemically competent cells (50µl aliquots, storage -80 °C) were thawed on ice and transformed with
desired DNA. Cells were kept on ice for 20min and heat-shocked for 1min in a water bath (42 °C).
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Figure 2.1: NotI Digestion and Religation of the EZ-Tn5<NotI/KAN-3> Transposon
EZ-Tn5TM In-Frame Linker Insertion Kit, EPICENTRE
Before striking out on LB-agar plates cells were additionally stored on ice for 2min. When working
with ampicillin resistance bacteria were immediately plated, for other resistance transformed bacteria
were added with 150µl of LB-medium and let grow
without antibiotics for 1 h at 37 °C in a shaker before plating onto LB-agar plates with the appropriate
antibiotic.
2.1.6 Preparation of chemically-competent E. coli
4ml LB medium were inoculated with the desired strain of E. coli and grown overnight without
supplementing with antibiotics. The next day culture was transferred into 300ml LB medium and
grown to an OD600 of 0.6. Next the suspension was placed on ice for 20min followed by harvesting
the cells by centrifugation at 2500 g for 20min (4 °C). Supernatant was discarded and the cells were
resuspended with 60 – 80ml of cooled Inoue transformation buffer. Again cells were harvested by
centrifugation at 2500 g for 15min (4 °C). Once more cells were resuspended with cooled Inoue
transformation buffer but this time with 20ml supplemented with 1.5ml DMSO. Suspension was
incubated on ice for 10min. Cells were aliquoted (50µl) and stored at -80 °C until usage.
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2.1.7 In-vitro mRNA transcription
The in-vitro RNA transcription was performed as per the T7 RIBOMAX™Express Large Scale RNA
Production System Kit. Accordingly, the DNA to be converted to RNA was cloned in pcDNA3
between T7 and Sp6. The DNA was then PCR amplified to yield good amount of the DNA product.
The PCR product is then purified and the concentration measured. For the next step of RNA in-vitro
transcription 1 – 1.5µg of DNA was used and accordingly the T7 Express 2X buffer was adjusted.
The following was the protocol followed for in-vitro transcription:
Reaction mix 30 µl (final volume)
DNA template 13 µl
RiboMAXTM Express T7 2X Buffer 15 µl
Enzyme Mix, T7 Express 2 µl
The reaction was incubated at 37 °C for 45min, after which the entire reaction sample was subject to
DNase treatment to get rid of the template DNA, according to the following protocol:
Reaction mix 75 µl (final volume)
RNA reaction sample 30µl
10X DNaseI Buffer 7.5 µl
RNase free DNaseI 3.75 µl
Nuclease Free H2O 33.75 µl
After incubating the reaction tube for 15min at 37 °C, the reaction sample was purified to obtain clean
RNA. The purification was done using RNeasy kit from QIAGEN™ with the following steps: To the
75µl of sample, 2µl Nuclease free H2O was added. To this 350µl of RLT buffer was added and
mixed properly. Next 250µl of 95% Ethanol was added, mixed properly and all was added in an
RNeasy Spin column. The column was spun for 30 s at 10,000 rpm. The flow-through was discarded,
and 500µl of RPE buffer was added to the column, spun for 30 s at 10,000 rpm and the flow-through
was discarded. Again 500µl of RPE buffer were added to the column, the column was spun for 2min
at 10,000 rpm, the flow-through discarded and the column was put in a clean eppi. The empty column
was spun for 2min at 10,000 rpm. Next, the column was put in a clean autoclaved elution tube, 30µl
of pre-heated Nuclease Free H20 was added (pre-heated to 50 °C), the tube left to stand for 30 s and
then spun for 1min at 10,000 rpm. The RNA was eluted out in the tube. The amount of RNA was
measured and the value used to calculate the concentration of the RNA obtained.
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2.1.8 RNA isolation
HeLa cells were grown on a 10 cm petri dish. Once the cells are 60% confluent, they were transfected
with DNA. They were incubated overnight at 37 °C and 5% CO2. After that the cells were lysed
directly in the culture dish by adding 1ml of TRIzol Reagent and pipetted up and down multiple times
to break the cells. The homogenized cells were then incubated for 5min at RT (to cause complete
dissociation of the nucleoprotein complexes). 0.2ml of Chloroform per 1ml of TRIzol reagent was
added to the dish. The dish was shaken for roughly 15 s, by hand, and then incubated further for 2 –
3min. The cells were then transferred to an eppi and centrifuged at 12,000 g (2000 rpm) for 15min at
4 °C. After the centrifugation the mixture in the tube is separated into a lower red, Phenol-Chloroform
phase (as interphase), and a colorless upper aqueous phase. The RNA remains exclusively in the the
aqueous phase.
The aqueous phase containing the RNA was transferred to a fresh eppi and 0.5ml of Isopropanol
per 1ml of TRIzol used for initial homogenization was added to precipitate the RNA. The samples
were incubated for 10min at RT and rotated for 10min at RT. The RNA precipitate formed a gel-like
pellet on the side and bottom of the tube. Carefully the supernatant was pipetted out. The RNA pellet
was washed once with 75% ethanol and 1ml of 75% ethanol (per 1ml of TRIzol added for initial
homogenization) was added to this pellet. The sample was then vortexed for 5min at 7000 g. Finally,
the RNA pellet was dried briefly (air-dried) for 5 – 10min, but not completely. Then the RNA pellet
was dissolved in RNase-free water and incubated for 10min at 55 °C – 60 °C. The re-dissolved RNA
can be stored at -80 °C. 1µl from the sample was taken for cDNA synthesis to get sample for Q-PCR.
2.1.9 cDNA synthesis
The RNA sample obtained by RNA isolation is treated with DNases to remove DNA contamination.
Mix for cDNA Synthesis
RNA Sample 20µl
10X DNaseI Buffer 3µl
RNase-Free DNaseI 1µl
RNase Free Water 10µl
The above reaction mix was incubated it for 30min at 37 °C. Next 200µl of RNA binding buffer
(100µl) + Ethanol 95 – 100% (100µl) was added and it was mixed well. The mixture was transferred
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to a ZYMO-SPIN™ IC column in a collection tube and centrifuged at 12000 x g for 1min. The flow
through was discarded. 800µl of RNA wash buffer was added to the column and centrifuged again
at 12000 x g for 30 s. The flow though was discarded and the wash step was repeated with 400µl of
RNA Wash Buffer. The flow through was discarded and the ZYMO-SPIN™ column was centrifuged
at 12000 x g in an empty collection tube for 2min. The ZYMO-SPIN™ column was removed from
the collection tube and transferred into an RNAse free eppi. 6µl of DNase / RNase-Free Water was
added directly onto the column matrix and the column was allowed to stand for 1min at RT. The final
spin was given at 10000 x g for 30 s. The eluted RNA was then used for cDNA synthesis.
cDNA synthesis was done as per the protocol for ”High Capacity cDNA Reverse Transcription” kit
from APPLIED BIOSYSTEMS™. RNA concentration was measured, and the ratio for 260 / 280 and
260 / 230 was measured to check the purity of the RNA sample. The reaction mix was thus prepared:
RNA sample 2 µg (10µl)
10X RT Buffer 2µl
25X dNTP mic (100mM) 0.8µl
10X RT Random Primers 2µl
MultiScribe Reverse Transcriptase 1µl
RNase Inhibitor 1µl
Nuclease Free H2O 3.2µl
Total volume: 20µl
The reaction tube was kept at 25 °C for 10min, then it was subjected to 2 h at 37 °C and then 2 h at
85 °C. Finally the sample could be used for normal PCR reaction with the respective primers to check
for the bands corresponding to the correct DNA strand. The sample could also be stored at -80 °C.
2.1.10 Agarose gel
For a 1% gel in the small mold (10 x 7 cm2), 0.6 g Agarose (SIGMA-ALDRICH, Munich, Germany)
was mixed to 60ml of 1 x TAE to it. Agarose was boiled in a microwave oven until being completely
dissolved. The mixture was then poured into the small mold and ethidium bromide was added to a
final concentration of 0,5µg/ml. After the gel had cooled down, 30min, the sample was loaded on
the gel. The samples for loading on the gel were prepared with Orange G (SIGMA) and distilled water.
The gel was usually run at 77V for 1 h for better separation of the different length DNA fragments.
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TAE electrophoresis buffer is used, whose composition is described below:
Buffer Tris-Acetate (TAE)
Working solution 1x:
Tris-Acetate 0.04 M
EDTA 0.001 M
Concentrated Stock (per Liter) 50x:
Tris base 242 g
Glacial acetic acid 57.1 ml
EDTA (pH 8.0) 100 ml 0.5 M
2.2 Protein biochemistry
2.2.1 Protein expression using the E. coli BL21 strain
DNA for the protein of interest was cloned in the pRSETB vector that is optimized for protein ex-
pression and carries a 6 xHis-tag 5’ of the multiple cloning site. The vector containing the DNA of
interest was transformed in the E. coli strain BL21. It was incubated for 30min and then added to
4ml of LB media, plus 4µl of Ampicilin. The culture was grown overnight on a shaker at 37 °C. The
next morning the culture was transferred to 800ml of LB, plus 800µl of Ampicilin. It was grown on
the shaker at 37 °C till the OD of the culture at 600 nm is between 0.7 to 0.8, then 100µM of IPTG
was added to the culture. The culture was grown overnight at 18 °C. The next day the culture was
centrifuged at 6000 rpm for 10min.
2.2.2 Purification of His-tag proteins via affinity chormatography
Protein Re-suspension & Wash buffer:
Na2PO4 20mM
NaCl 300mM
pH 7.8
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Elution Buffer:
Na2HPO4 20mM
NaCl 300mM
Glycerol 10%
Imidazol 250mM
pH 7.8
Using His-Trap column from GE HEALTHCARE:
The supernatant was thrown out and the pellet was re-suspended in 20ml protein re-suspension &
wash buffer. 20µl PMSF (1M in DMSO), 20µl Pepstatin (1mg / ml in DMSO) and 20µl Leupeptin
(1mg / ml in DMSO) were added. The re-suspended cells were frozen at -80 °C for at least 1 hour.
Afterwards the cells were thawed, and one spatula head of Chicken Egg White Lyzozyme was added,
and incubated on ice for 30min. Then 50µl of DNAase (1mg /ml in 10% Glycerol) was added,
0.1% Triton X100, and sonicated with ice for 30min. The cells were then centrifuged at 13000 rpm
for 30min. The supernatant was taken in a falcon tube and the pellet discarded. The protein sample
was then run for affinity chromatography on a His-Trap column (GE HEALTHCARE).
First, 5ml of dd (double distilled) water was run through the column at the run speed of 0.5ml per
minute. Next 5ml of protein re-suspension &wash buffer was run through the column. Afterwards the
protein sample supernatant was run through the column, followed by 20ml of protein re-suspension
& wash buffer. Next, the elution buffer was run through the column and the fluorescent fraction from
the column was collected in an eppi. It was kept overnight at 4 °C.
Using Ni-NTA HisBind Resin:
The supernatant was thrown out and the pellet was re-suspended in 20ml protein re-suspension &
wash buffer. 20µl PMSF (1M in DMSO), 20µl pepstatin (1mg /ml in DMSO) and 20µl Leupeptin
(1mg /ml in DMSO) were added. The re-suspended cells were frozen at -80 °C for at least 1 h. After
that the cells were thawed, and one spatula head of Chicken Egg White Lyzozyme was added, and
incubated on ice for 30 minutes. Then 50µl of DNAase (1mg /ml in 10% Glycerol) was added,
0.1% Triton X100, and sonicated with ice for 30min. The cells were then centrifuged at 13000 rpm
for 30min. The supernatant was taken in a falcon tube and 50% NiNTA resin (600µl) was added.
It was rotated with a table rotator for 4 h and then the solution was passed through Polypropylene
columns (QIAGEN). Once the solution passes through the columns, the NiNTA beads settle at the
bottom of the column. It was washed by passing through the column protein re-suspension solution
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3 x 5ml. Then 1.2ml elution buffer was added in the column, the base of the column was closed.
The elution buffer was pipetted up and down 2 – 3 times to mix well with the NiNTA beads. It was
allowed to stand for 20min and then the protein was eluted out of the column in the elution buffer and
collected in an eppi. The protein sample was stored at 4 °C overnight.
The next day the protein sample was run through the ÄKTA column for ion exchange chromatography.
The flow through fractions were collected and the ones showing the highest value for the protein
concentration and fluorescence ( determined via the graph of the sample run via ÄKTA) were pooled
together and concentrated to 2ml of the sample. This was the pure protein sample finally obtained via
protein purification.
The purified sample for mKO2 and mKO2-Lambda constructs was then measured via a spectropho-
tometer to measure its extinction coefficient and run also on an SDS-PAGE to check the purity of the
protein sample. To the remaining protein Glycerol was added (10%) and it was shock frozen in liquid
nitrogen and stored at -80 °C.
ÄKTA Buffer:
MOPS 30mM
KCl 100mM
EDTA 100µM
EGTA 100µM
ph 7.2
Stripping Buffer:
MOPS 30mM
KCl 500mM
EDTA 100µM
EGTA 100µM
ph 7.2
Recharging Buffer:
NiSO4 100mM
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After that the protein sample was run through the ÄKTA column for ion exchange chromatography.
The flow through fractions were collected and the ones showing the highest value for the protein
concentration and fluorescence (determined via the graph of the sample run via ÄKTA) were pooled
together and concentrated to 2ml of the sample. This was the pure protein sample thus yielded via
protein purification.
The purified sample for mKO2 and mKO2-Lambda constructs was then measured via a spectropho-
tometer to measure its extinction coefficient and run also on an SDS-PAGE to check the purity of the
protein sample. To the remaining protein sample Glycerol (final concentration 10%) was added and
it was shock frozen in liquid nitrogen for subsequent storage at -80 °C.
2.2.3 Spectrophotometer measurements of the fluorescent proteins for calcu-
lating extinction coefficient and quantum yield
The fluorescent proteins obtained via protein purification were concentrated using Amicon Ultra Cen-
trifugal filter devices (MILLIPORE). Therefore the protein fractions showing the maximum protein
and fluorescence peaks values, from the ÄKTA profile of protein purification, were collected in the
Amicon Ultra Centrifugal filter devices (MILLIPORE) and the tube was centrifuged at 4000 rpm for
10min at 4 °C. After concentration of the protein, the protein sample was collected in a 2ml eppi
and the flow through was collected in another 2ml eppi and used as a buffer blank for the spectra
measurements.
Absorption Spectroscopy:
The CARY UV-Spectrophotometer from VARIAN was used to measure the spectra. The wavelength
used was between 240 – 600 nm (to measure both the protein and fluorescence of the protein). 1ml of
blank was added in the cuevette and the baseline was set. Next 5µl of the protein sample were added
to the blank and the measurements were made by subsequently increasing the volume of the protein
in the cuevette.
Fluorescence spectroscopy of mKO2 variants:
Emission spectra were excited at 520 nm and measured between 530 nm and 640 nm. After that,
spectra were used to calculate e520, e550 and the quantum yield compared to mKO2 (see results).
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2.2.4 Gel electrophoresis: denaturing SDS-PAGE
The separation of denaturated proteins was carried out using sodium dodecyl sulfate (SDS) gel elec-
trophoresis. For separation of proteins in the desired range a 8% SDS-polyacrylamide gel was used.
The acrylamide stock solution was Protogel (mixture 30% Acrylamide, 0.8% Bisacrylamide).
SDS Page Separation Gel (10%):
H2O 2400µl
1.5M Tris Buffer (pH 8.8) 1250 µl
40% Acrylamide mixSIGMA 1250 µl
10% SDS (pH 7.2) 50 µl
10% Ammonium PersulfateSIGMA 50 µl
TEMEDSIGMA 2 µl
SDS Page Stacking Gel (5%):
H2O 1440µl
1M Tris Buffer (pH 6.8) 250 µl
40% Acrylamide mixSIGMA 250 µl
10% SDS (pH 7.2) 20 µl
10% Ammonium PersulfateSIGMA 20 µl
TEMEDSIGMA 2 µl
Loading-buffer6X, pH 6.8:
Tris HCl 350 mM
SDS (w/v) 10%
Glycerol (v/v) 30%
Bromophenol blue (w/v)
(Serva-blue G) 0.1%
β-mercaptoethanol (v/v) 12%
Dithiothreitol (w/v) 9.3%
All solutions were mixed in screw-capped falcon tubes with very gentle rocking. The separation gel
polymerised for 30min in the electrophoresis apparatus, with a layer of Isopropanol overlaid, to fasten
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the polymerisation by avoiding contact with oxygen. Then, after removing the Isopropanol, the stack-
ing gel was poured and polymerized for 45min. After loading of the samples on the polymerized gels,
they migrated at 30V for around 1 h 30min. For sample preparation, I mixed the 6X loading buffer at
a ratio sample/buffer 3 / 1 to maintain an excess of SDS. The samples were heated immediately after
adding sample buffer for 10min at 95 °C, and then loaded immediately.
Coomassie-blue staining, modified
Chemicals /
Buffers
Serva-blue
G-250 (w/v)
Acetic Acid
(v/v)
Methanol
(v/v)
Staining Sol 0.25% 10% 5%
De-staining - 10% 40%
After running the gel, the SDS gel was removed from the electrophoresis apparatus and put into a
square plastic chamber (to keep the gel flat and not folded) and stained with staining solution, heated
for 1 minute and gently rocked overnight at room temperature. The next day, the stain was removed,
de-staining solution was added and heated for 1 minute, and gently rocked for 20min. The de-staining
process was repeated until the band became visible. Then some dd H2O was added and the gel was
rocked for a couple of hours before it was imaged.
2.2.5 BCA assay for protein concentration
Protein concentrations were measured before FRET analysis using BCA Protein AssayThermofisher
kit. In this method, 8 diluted BSA standards were prepared from the range of 2,000µg/ml – 25µg/ml
and there was one blank, using the Elution Buffer used to elute out the proteins as the dilutant. The
working reagent was formed with one part of Reagent B + 50 parts of Reagent A. Microplates were
used for the measurements, therefore 200µl of the Working reagent was added to each well of the
microplate and 10µl of the BSA diluted standard, one dilution per well, therefore 9 such wells for
the standards. The standards were done in triplicates. For the samples, 10µl was added to each well,
also done in triplicates. The microplate was then shaken for 30 s, covered with an aluminum foil and
kept at room temperature for 2 h before the reading was taken on an ELISA plate reader at 550 nm.
A graph is formulated from the average-blank values for the standards. The sample values are also
average-blank calculated and then from the graph the concentration of the protein is calculated for
each sample.
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2.2.6 In-vitro FRET measurements to study aptamer induced FRET upon
binding of the λN tagged fluorescent proteins
The measurements were done with a CARY ECLIPSE fluorescence spectrophotometer (VARIAN). In a
microcuevette RNA binding buffer was added and 0.1µM of the donor protein, i.e. EGFP or mTFP1
and 0.1µM of m acceptor protein, i.e. mKO2 variants, are added. The EGFP/mKO2(or mKO3)
FRET constructs were excited at 460 nm and the emission was recorded from 490 nm to 650 nm. For
the mTFP1/mKO2(or mKO3) FRET constructs were excited at 458 nm and the emission was recorded
from 480 nm to 650 nm. Then 0.1µM of RNA was added (1 xRNA), mixed properly and the spectra
was again measured. Another reading with another 0.1µM of the RNA (2 x RNA) was performed.
The final volume in the cuevette was always kept at 100µl.
RNA-binding buffer:
Tris pH 7.8 20 mM
MgCl2 10 mM
NaCl 300 mM
To calculate the ∆R/R value on addition of the aptamer the following formula was used:
∆R
R
= RatioRNA−Ratiozero
Ratiozero
where Ratio for EGFP/mKO2(or mKO3) constructs = PeakmKO2(3)/PeakEGFP (570 nm/508 nm), and
Ratio for mTFP1/mKO2(or mKO3) constructs = PeakmKO2(3)/PeakmTFP (570 nm/490 nm).
2.3 Cell culture
2.3.1 Preparation of HeLa cells culture
The HeLa cells stock, kept in -80 °C, was melted in water bath at 37 °C. The contents from the HeLa
cells eppi were added to a falcon tube containing 5ml of DMEM. Centrifuge the falcon at 1200 rpm
for 4min ( rotor number 19777, Centrifuge: SIGMA, 3K30 ). Discarded the supernatant and re-
suspended the pellet in 5ml DMEM. 4.5ml of this re-suspended media and cells was added to 10
cm petri dish containing 5ml DMEM with 10% FCS (Fetal Calf Serum). The media was changed
the next day. Check the confluency of the cells, when they are 90% confluent, the DMEM media
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was removed. The cells attached to the bottom of the dish were washed with 4ml of 1XPBS, twice.
2ml of 0.25% Trypsin was added, and the cells were incubated with Trypsin for 5min. Next, the
Trypsin was pipetted out and the cells washed once with 1XPBS. 8ml of fresh DMEM media was
added, titrated the cells with pipette and one drop from this was added to glass-bottom dishes (MTek)
containing 2ml of DMEM ( with 10% FCS).
2.3.2 Transfection of HeLa cells culture using lipofectamine
LIPOFECTAMINE™ 2000 Standard Plasmid Transfection reagent was used for transfection of HeLa
cells. For plasmid transfection, the DNA to Lipofectamine ratio for transfection was 2 : 1 or 3 : 1
respectively. The cells were transfected if they were 60% confluent. First, 6µl lipofectamine were
added to 250µl OptiMEM for subsequent 5min of incubation. Next, DNA was added to 250µl
OptiMEM, depending on the concentration of the plasmid DNA so as to keep the ratio of Lipofec-
tamine : DNA as 1 : 2 or 1 : 3. The DNA and OptiMEM mixture was added to the Lipofectamine tube
and given a slight tap, and left to incubate for 20min at room temperature. After 20min, 500µl of
conditioned media was taken out from the dish of cells, to be added later. The DNA+Lipofectamine
was added onto the cells, drop-wise, and left to incubate at 37 °C, 5% CO2 for 3 h. After 3 h the cells
were washed with 2ml of 1XPBS, twice. Fresh DMEM (10%FCS) and the 500µl of conditioned
media was added. The cells were left at 37 °C and 5% CO2 incubator overnight and imaged the next
day.
2.3.3 Confocal imaging of transfected HeLa cells
The images were acquired with a LEICA TCS SP2 confocal laser scanning microscope. The lens used
was 40X oil immersion, 488 nm excitation laser was used for EGFP and for YFP 514 nm excitation
laser was used.
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2.4 Materials
2.4.1 Primers list
Primers for 1λN22peptide
5’Lmbda_mKO2ORF1:
ACATCGGGCGGCCGCAAGCCACCATGGACGCACAAACAC
NotI
3’Lmbda_mKO2ORF1:
ACATCGGGCGGCCGCGGTGGGTTTGCAGCTTTCCATTG
NotI
5’Lmbda_mKO2ORF2:
ACATCGGGCGGCCGCAGCCACCATGGACGCACAAACAC
NotI
3’Lmbda_mKO2ORF2:
ACATCGGGCGGCCGCCGGTGGGTTTGCAGCTTTCCATTG
NotI
5’Lmbda_mKO2ORF3:
ACATCGGGCGGCCGCGCCACCATGGACGCACAAACAC
NotI
3’Lmbda_mKO2ORF3:
ACATCGGGCGGCCGCGCGGTGGGTTTGCAGCTTTCCATTG
NotI
mKO3-λN
5’mKO3 (mKO3-BamHI):
CGGGATCCGAAGCTTGCCACCATGGTGAGTGTGATTAAACCAG
BamHI
3’mKO3 (mKO3-SacI):
ACATCGGGAGCTCGGTACCGCCCTTGTACAGCTCGTCCA
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SacI
5´Lambda:
ACATCGGGAGCTCGCCACCATGGACGCACAAACA
SacI
3´Lambda:
ACATCGGGAATTCTTACGGTGGGTTTGCAGCTTTCCATTG
EcoRI
λN-mKO3
5’mKO3 (mKO3-SacI):
CGAGCTCATGGTGAGTGTGATTAAACCAG
SacI
3’mKO3 (mKO3-EcoRI):
GGAATTCATCGATTCAGCTATGAGCTACTGCATCTTC
EcoRI
5’Lambda:
ACATCGGGGATCCGGCCACCATGGACGCACAAACA
BamHI
3´Lambda:
ACATCGGGAGCTCCGGTGGGTTTGCAGCTTTCCATTG
SacI
Primers for donor proteins
mTFP1 _Lambda
5’mTFP1:
ACATCGGGGATCCGGCCACCATGGTGAGCAAGGGCGAGGAGACCAC
BamHI
3´mTFP1:
ACATCGGGAGCTCCTTGTACAGCTCGTCCATGCCGTC
SacI
5´Lambda:
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ACATCGGGAGCTCGCCACCATGGACGCACAAACA
SacI
3´Lambda:
ACATCGGGAATTCTTACGGTGGGTTTGCAGCTTTCCATTG
EcoRI
Lambda_mTFP1:
5’Lambda:
ACATCGGGGATCCGGCCACCATGGACGCACAAACA
BamHI
3´Lambda:
ACATCGGGAGCTCCGGTGGGTTTGCAGCTTTCCATTG
SacI
5´mTFP1:
ACATCGGGAGCTCATGGTGAGCAAGGGCGAGGAGACCAC
SacI
3‘mTFP1:
ACATCGGGAATTCTTACTTGTACAGCTCGTCCATGCCGTC
EcoRI
EGFP _Lambda:
5’EGFP:
ACATCGGGGATCCGATGG TGAGCAAGGGCGAGGAGCTG
BamHI
3’EGFP:
ACATCGGGAGCTCCTTGTACAGCTCGTCCATGCCGAG
SacI
5´Lambda:
ACATCGGGAGCTCGCCACCATGGACGCACAAACA
SacI
3´Lambda:
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ACATCGGGAATTCTTACGGTGGGTTTGCAGCTTTCCATTG
EcoRI
Lambda_EGFP:
5’Lambda:
ACATCGGGGATCCG GCCACCATGGACGCACAAACA
BamHI
3´Lambda:
ACATCGGGAGCTCCGGTGGGTTTGCAGCTTTCCATTG
SacI
5´EGFP:
ACATCGGGAGCTCATGG TGAGCAAGGGCGAGGAGCTG
SacI
3´EGFP:
ACATCGGGAATTCTTACTTGTACAGCTCGTCCATGCCGAG
EcoRI
Primers for 5boxB DNA
5’_pcDNA3_5boxB:
ACATCGGAAGCTTTACGCCCTGAAAAAGGGCTGTACAGCCCTG
Hind III 5boxB
3’_5boxB_thibox_2 :
ACATCGGGGTACCCGCCCTTTTTCAGGGCG
KpnI 5boxB
Primers for 5boxB PCR for in vitro transcription
5’ T7 Primer:
TAATACGACTCACTATAGGG
3’_Sp6 Primer :
CATTTAGGTGACACTATAG
Riboswitch
5’_5boxB_thibox_2:
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AGTGGATCC GAATTCTACGCCCTGAAAAAGGGCTGTACAGCCCTG
BamHI EcoRI 5boxB
3’_5boxB_thibox_2 :
ATAAGATCTCGCCCTTTTTCAGGGCGTCG
BglII 5boxB
Fw_MS6_thibox_2:
CGCCCATGGTAATTGCCTAGAAAACATGAGGATC
NcoI MS-BS
Rv_MS6_thibox_2 :0
CAAAAGCTTGCGGCCGCTTAGGATCTAATGAACCCGGG
HindIII NotI
thiM_5UTR_2_5’:
ATTAGATCTGGAACCAAACGACTCGGGGTGC
BglII
thiM_5UTR_2_3’:
ATACCATGGTTGCGCTGGATCCAGCAGGTCG
NcoI
2.4.2 Instruments
Name Supplier
Cary 100 Scan UV-Visible Spectrophotometer VARIAN, Mulgrave (Australia)
Cary Eclipse Fluorescence Spectrophotometer VARIAN, Mulgrave (Australia)
Dyad DNA Engine Peltier Thermal Cycler MJ RESEARCH INC., Waltham (USA)
NANODROP spectrophotometer NANODROP TECHNOLOGIES (USA)
LEICA MICROSYSTEMS TCS SP2 Confocal microscope LEICA MIKROSYSTEME GmbH,
Heidelberg (Germany)
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2.4.3 Consumables
Name Supplier
BCA Protein Assay kit THERMO FISHER SCIENTIFIC (Germany)
EZ-Tn5TM In-Frame Linker Insertion kit EPICENTRE (USA)
Glass Bottom Culture Dishes 35mm, No. P35G-0-14-C MATTEK CORP., Ashland (USA)
High Capacity cDNA Reverse Transcription Kit APPLIED BIOSYSTEMS (Germany)
Polypropylene Columns Qiagen HILDEN (Germany)
PUREYIELD™ Plasmid Miniprep System PROMEGA (Germany)
QIAQUICK Gel Extraction Kit Qiagen HILDEN (Germany)
QIAQUICK PCR Purification Kit Qiagen HILDEN (Germany)
QIAQUICK Spin Miniprep Kit Qiagen HILDEN (Germany)
T7 RIBOMAX™ Express Large Scale RNA Production System Kit PROMEGA (Germany)
2.4.4 Buffers, solutions and media
Name Recipe
DMEM/10 % FCS 500 ml DMEM
50 ml FCS, heat-inactivated
DNA Gel Loading Buffer (10 x) 100 mM Tris/HCl, pH 7.5
10 mM EDTA
50 % Glycerol
1 % Orange G
HBSS for imaging 25 mM HEPES pH 7.4
140 mM NaCl
5 mM KCl
1 mM CaCl2
1 mM MgCl2
1 mM Glucose
0.25% BSA
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LB (Luria-Bertani) medium 20 g/l LB broth base in ddH20
pH 7,0
LB Agar LB Medium 15 g Agar in 1 l ddH2O
PBS (10 x) 100 mM Na2HPO4, pH 7.4
20 mM KH2PO4
1.37 M NaCl
27 mM KCl
Poly-L-Lysine 0.01 % (w/v) Poly-L-Lysine
Hydrobromide in H2O
2.4.5 Chemicals
Name Supplier
Agar SIGMA, St. Louis (USA)
Ampicillin, sodium salt ROTH, Karlsruhe (Germany)
β-mercaptoethanol;
Chloroform MERCK, Darmstadt (Germany)
DMSO (Dimethylsulfoxide) SIGMA, St. Louis (USA)
Dulbecco’s modified Eagle’s medium INVITROGEN, Carlsbad (USA)
(DMEM) w/o Sodium Pyruvate;
w/ 4500 mg/ml Glucose;
w/ Pyridoxine-HCl SIGMA, St. Louis (USA)
EGTA (Ethylene glycol bis(beta-amino
ethyl ether tetra-acetic acid)
Formaldehyde MERCK, Darmstadt (Germany)
HEPES free acid SIGMA,St. Louis (USA)
Imidazole MERCK, Darmstadt (Germany)
Isopropyl β-D-1-thiogalactopyranoside SIGMA,St. Louis (USA)
Leupeptin hydrochloride SIGMA, St. Louis (USA)
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Lipofectamine INVITROGEN, Carlsbad (USA)
Lysozyme SIGMA, St. Louis (USA)
Ni-NTA Agarose QIAGEN, Hilden (Germany)
Opti-MEM I INVITROGEN, Carlsbad (USA)
Pepstatin A SIGMA, St. Louis (USA)
Phenylmethylsulfonylfluoride (PMSF) SIGMA, St. Louis (USA)
Poly-L-lysine hydrobromide SIGMA, St. Louis (USA)
Potassium chloride MERCK, Darmstadt (Germany)
Sodium bicarbonate SIGMA, St. Louis (USA)
Sodium chloride SIGMA, St. Louis (USA)
Sodium dodecyl sulfate Sigma, St. Louis (USA)
Sodium phosphate monobasic, SIGMA, St. Louis (USA)
anhydrous
T4-Ligase NEW ENGLAND BIOLABS, Beverly (USA)
Triton-X-100 SIGMA, St. Louis (USA)
Trypsin SIGMA, St. Louis (USA)
64
Chapter 3
Results
3.1 Generation of mKO2 variants with λN22 insertions
The mKO2 variants with NotI restriction enzyme sites introduced via EZ-Tn5 transposon used for
λN22 ligation were variants number: 49, 51, 53, 88, 90, 92, 162, 186, 188 and 210. These variants
were selected as they were tolerant to EZ-Tn5 insertions and yielded fluorescent colonies during
screening on agar plates. Numbering of these mKO2 variants is dependent on the position of the
amino acid, in the mKO2 protein sequence, where the transposon is inserted. All the cloning work
was done in pRSETB vector, the map of which is given in figure 3.1.
The mKO2 variants chosen for the project had NotI restriction enzyme site inserted in one of the
following amino acid positions for mKO2: 49, 51, 53, 54, 88, 90, 92, 186, 188 and 210, as shown in
figure 3.2.
The λN22 sequence was obtained via PCR usind p4LambdaN22-mEGFP3-m9 as template (obtained
from Dr. Jan Ellenberg’s Lab, EMBL, Heidelberg) with NotI restriction enzyme sites on both ends
and was ligated in the modified mKO2 variants, as shown in figure 3.3. Colonies obtained after
ligation were fluorescent for all variants except #210. Ten colonies per ligation plate were picked to
check for the insertion of λN22 and sequence analysis.
In addition to cloning of mKO2 variants with λN22 inserted in different positions, I also generated
variants tagged with λN22 either at the N- or the C-terminus of mKO3 as shown in figure 3.4. For
this, I used a modified mKO2 version where the C-terminus has been mutated to introduce the last 9
amino acids of the Aequorea GFP C-terminus. Thus, the mKO2 has a GFP C-terminus and is tolerant
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Figure 3.1: pRSETB Vector map
Figure 3.2: Amino acid positions in mKO2 where the NotI site is inserted via EZ-Tn5 transposon
element is inserted
to C-terminus tagging. This mutated mKO2 as been termed as mKO3, for ease of differentiation
from mKO2.All colonies obtained after λN22 ligation with mKO3 were fluorescent and 8 colonies per
ligation plate were cultured and control digested to check for the insertion of the λN22 fragments and
sequenced to check the orientation of λN22.
The clones showing the correct insertion of λN22 were set for protein purification and the purified
proteins were run on an SDS gel to check for the purity of proteins as shown in figure 3.5.
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Figure 3.3: Schematic representation of λN22 insertion in mKO2 containing transposon introduced
NotI site
(a)
(b)
Figure 3.4: Schematic representation of mKO3 tagged at (a) N-terminus and (b) C-terminus withλN22
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(a) ÄKTA purified mKO3-λN22 variants and purified EGFP-λN22
variants
(b) ÄKTA purified mKO2-λN22 variants
Figure 3.5: SDS PAGE run for purified λN22 variants
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3.2 Comparing the fluorescent properties of themKO2-λN22 vari-
ants
The λN22 inserted mKO2 variants were characterized for their fluorescent properties i.e. quantum
yield and extinction coefficient.
Figure 3.6 shows the absorption spectra of mKO2-λN22 variants compared to that of mKO2 (WT)
(wild type). The spectra of the mKO2-λN22 variants have been adjusted to the absorbance at 280 nm.
Figure 3.6: Absorption spectra of the mKO2-λN22 variants in comparison to mKO2 (WT)
The concentrations of proteins in solutions were calculated from the absorption at 280 nm using the
calculated extinction coefficient obtained using the program: www.expasy.ch/tools/protparam.html.
To calculate the extinction coefficient, the amino acids forming the chromophore were excluded. The
fluorescence emission of the proteins was measured. For that the concentrations of all the proteins
measured were diluted to have the same final concentration in the cuevette. Figure 3.7 shows the
emission spectra of the different mKO2-λN22 variants in comparison to the mKO2 (WT).
The quantity of absorbed photons at 520 nm is given through the ratio of extinction coefficients at
520 nm via the equation:
F1 = ε520,mKO2ε520,variant ;
where
ε520,mKO2 is the extinction coefficient of mKO2 at 520 nm, and
ε520,variantis the extinction coefficient of mKO2-λN22 inserted variant at 520 nm.
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(a) mKO2-λN22 variants in comparison to mKO2 (WT) (b) mKO3-λN22 and λN22-mKO3 in comparison to
mKO2 (WT)
Figure 3.7: Fluorescence emission spectra of various mKO2-λN22 (a) and mKO3-λN22 (b) variants in
comparison to mKO2 (WT)
Emitted photons were quantified by calculating the ratio of emission at 563 nm (emission maximum)
via the following equation:
F2 = ε563,mKO2ε563,variant ;
where
ε563,mKO2is the extinction coefficient of mKO2 at 563 nm, and
ε563,variantis the extinction coefficient of mKO2-λN22 inserted variant at 563 nm.
After calculating these factors, the quantum yield (QY) of mKO2-λN22 and mKO3-λN22 variants was
calculated from the QY of mKO2 (WT) as shown in the following equation:
QYvariant = QYmKO2F1F2
where
QYvariant depicts the quantum yield of the mKO2-λN22 inserted variant, and
QYmKO2 is the quantum yield of mKO2 = 0.57 (45).
Table 3.1 shows an overview of the spectral properties of mKO2-λN22 and mKO3-λN22 variants in
comparison to mKO2 (WT) with
The ε549 was calculated as given in the following equations:
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Sample Extinction
coefficient
280 nm
(M−1cm−1)
Extinction
coefficient at
549 nm
(M−1cm−1)
Quantum
Yield
Result Conc.
[µM]
mKO2_l #49 33140 74498.72 0.52 31
mKO2_l #51 34630 67286.09 0.47 21
mKO2_l #53 34630 13796.6 9
mKO2_l #54 33140 73637.08 0.51 45
mKO2_l #88 34630 46092.53 0.37 14
mKO2_l #90 34630 51910.37 0.44 9
mKO2_l #92 40130 57385.9 0.62 16
mKO2_l #169 34630 9706.8 1.41
mKO2_l #186 40130 79537.66 0.41 9
mKO2_l #188 33140 45302.38 5
mKO3_l 32890 74660 0.56 43.25
l_mKO3 33015 75934.5 0.53 41
mKO2 (WT) 25900 67892 0.57 113
Table 3.1: Overview of spectral properties of generate mKO2-λN22 & mKO3-λN22 variants
ε549 = ε280Abs549Abs280 ;
where Abs549is the absorbance at 549 nm and Abs280 is the absorbance at 280 nm.
After evaluating the fluorescent properties of the mKO2-λN22 and mKO3-λN22 variants, I selected
the following for the aptamer induced FRET experiments: mKO2-λN22 variants # 49, 51, 54, 92,
186, mKO3-λN22 and λN22-mKO3. For FRET experiments, the rate of energy transfer is influenced
by the quantum yields of both the donor and acceptor; and the lifetimes of the fluorescent proteins,
which can be evaluated from the absorption spectra, extinction coefficient and the emission spectra.
The constructs mKO2-λN22#49, 51, 54, 92, 186, mKO3-λN22 and mKO3-λN22 exhibited high values
for quantum yield, extinction coefficient at 549 nm and higher absorption spectra than mKO2 (WT).
The remaining constructs #53,88,90,169 and 188 had very poor absorption spectra and low values for
extinction coefficient at 549 nm. Therefore, the mKO2-λN22 variants # 49, 51, 54, 92, 186, mKO3-
λN22 and λN22-mKO3 were selected for FRET experiments.
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3.3 Generation of FRET donors proteins tagged with λN22
The donor proteins used for the experiment were EGFP and mTFP1. λN22 PCR product was ligated
with EGFP and mTFP in a pRSETB vector as shown in figure 3.8
(a)
(b)
Figure 3.8: Schematic representation of mTFP1 tagged at (a) N-terminus and (b) C-terminus with
λN22
and figure 3.9. . The donor proteins were tagged with λN22 either at the N-or C-terminus. All colonies
obtained on the ligation plates were fluorescent. Eight colonies per ligation plate were picked for
harvesting the culture and later screened to verify the correct sequence. The clones with the correct
DNA sequence were set for protein purification and purity checked by running the protein sample on
a SDS gel. BCA assay was performed to obtain the concentration of the proteins.
SDS-gels ran for the purified proteins as depicted in the figures 3.10a, 3.10b and 3.5a.
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(a)
(b)
Figure 3.9: Schematic representation of EGFP tagged at (a) C-terminus and (b) N-terminus with λN22
(a) mTFP1 and mTFP1-λN22 (b) λN22-mTFP1
Figure 3.10: SDS PAGE for purified proteins
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3.4 Studying aptamer induced FRET
To study aptamer induced FRET upon binding of λN22 tagged fluorescent proteins, in-vitro experi-
ments were conducted in a cuevette and FRET was measured via a photometer. The acceptor proteins
were the λN22 inserted mKO2 variants, #s 49, 51, 54, 92, 186; and mKO3 tagged N- and C-terminally
with λN22. The donor proteins were EGFP and mTFP1 tagged with λN22 at the N- and C-terminus.
The cognate sequence for binding is the boxB RNA. For in vitro FRET experiments 5boxB RNA
sequence was transcribed in vitro using T7 and Sp6 primers from a pcDNA3-5boxB. This construct
was generated using a 5boxB PCR fragment and inserted in pCDNA3 as shown in figure 3.11.
Figure 3.11: Schematic representation of pcDNA3-5boxB construct for in vitro RNA transcription
The sequence of 5boxB RNA is shown below:
TACGCCCTGAAAAAGGGCTGTACAGCCCTGAAAAAGGGCTCGA
GCCCTGAAAAAGGGCAATTGCCCTGAAAAAGGGCGTCGACGCCCTGAAAAAGGGCG
where the boxB sequence is highlighted in red.
To check that the transcribed RNA is a single pure band, it was run on a non-denaturating agarose
gel. There was more than one band found in the transcribed RNA lane. On heating the product to
95 °C and quick cooling, again there were two bands found in the transcribed 5boxB RNA lane. To
ascertain the purity of transcribed RNA, the RNA was reverse transcribed to obtain a cDNA product.
The template PCR DNA, in vitro transcribed RNA and the cDNA were then run together on a non-
denaturating gel as shown in figure 3.12.
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Figure 3.12: Gel picture showing the 5boxB template DNA used for in vitro transcription, the tran-
scribed RNA and the cDNA synthesized from the transcribed RNA
The size of the cDNA band synthesized from the transcribed RNAwas the same as for the initial DNA
template used for RNA transcription, which indicated that the correct RNA is transcribed via in vitro
transcription. The transcribed RNA showed more than one band when ran on an agarose gel, which
as per Francisco J. Triana-Alonso et al. [60], might be RNA-coded de novo synthesis or self-coded
3’-end extension event occurring. This can happen if the UTP concentration in the buffer is high as
then the T7 polymerase might accept the 3’ end of the newly transcribed RNA which is free from
secondary structure and start extending the 3’end of the RNA. This results in a secondary product
which is half the double size of the RNA. Here, from the gel it is clear that the cDNA synthesized
from the RNA gives the same size band as the template DNA. Therefore, the transcribed RNA is
correct. But it is possible that some transcribed RNA molecules might have longer sequences than
5boxB fragment with additional nucleotides.
The concentration c of the in vitro transcribed RNA was calculated as shown in the formula below:
c = γ
M
;
where γ is the specific weight in nuclease free water and M is the molecular weight.
The molecular weight was calculated using the following formula (from www.ambion.com ):
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M = Nnucleotides · 320.5 + 159;
where Nnucleotides is the number of nucloetides.
To conduct the FRET experiments, first the donor proteins were added and the fluorescence emission
spectra was recorded, next the acceptor was added and the emission spectra was recorded, finally the
RNA was added and the fluorescence emission spectra was measured. The molar concentrations of
the proteins and the RNA was kept in the same ratio(1:1:1) initially, later the concentration of RNA
was increased in the cuevette to two fold(1:1:2) to observe if it affected in the emission spectra (figures
A.1- A.7 appendix A).
Although there was no significant FRET change visible, the DR/R values were calculated for the
different FRET pairs using the equation given in the methods section 2.2.6 on page 55. Tables 3.2 on
the next page and 3.3 on page 78 show the obtained results from these calculations.
76
FRET Pair DR/R
EGFPl-mKO2l #49 1XRNA 0.152
2XRNA 0.097
EGFPl-mKO2l #51 1XRNA 0.016
2XRNA 0.067
EGFPl-mKO2l #54 1XRNA 0.07
2XRNA 0.38
EGFPl-mKO2l #92 1XRNA 0.072
2XRNA 0.056
EGFPl-mKO2l #186 1XRNA 0.059
2XRNA 0.0
EGFPl-mKO3l 1XRNA 0.029
2XRNA 0.029
EGFPl-lmKO3 1XRNA 0.015
2XRNA 0.11
FRET Pair DR/R
lEGFP-mKO2l #49 1XRNA 0.052
2XRNA 0.02
lEGFP-mKO2l #51 1XRNA 0.069
2XRNA 0.039
lEGFP-mKO2l #54 1XRNA 0.19
2XRNA 0.058
lEGFP-mKO2l #92 1XRNA -
2XRNA 0.053
lEGFP-mKO2l #186 1XRNA 0.004
2XRNA 0.021
lEGFP-mKO3l 1XRNA 0.05
2XRNA 0.039
lEGFP-lmKO3 1XRNA -0.02
2XRNA 0.011
Table 3.2: The table shows the FRET ratio change, ∆R/R , measured for the different λN22 tagged
donor and acceptor pairs on addition of 5boxB RNA in the cuevette. 1XRNA depicts equimolar
concentration of RNA, donor and acceptor proteins in the solution. 2XRNA depicts when the con-
centration of RNA was two folds higher than the concentration of the donor and acceptor proteins in
the solution. The∆R/R values are also shown as bar graphs below the tables to show the FRET ratio
change in the presence of RNA (1XRNA or 2XRNA) in comparison to zero RNA in the solution.
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FRET Pair DR/R
mTFP1l-mKO2l #49 1XRNA 0.002
2XRNA 0.118
mTFP1l-mKO2l #51 1XRNA 0.102
2XRNA 0.168
mTFP1l-mKO2l #54 1XRNA 0.008
2XRNA 0.064
mTFP1l-mKO2l #92 1XRNA -0.009
2XRNA -0.12
mTFP1l-mKO2l #186 1XRNA -0.019
2XRNA 0.026
mTFP1l-mKO3l 1XRNA 0.01
2XRNA 0.156
mTFP1l-lmKO3 1XRNA 0.008
2XRNA 0.076
FRET Pair DR/R
lmTFP1-mKO2l #49 1XRNA 0.067
2XRNA 0.069
lmTFP1-mKO2l #51 1XRNA 0.039
2XRNA 0.115
lmTFP1-mKO2l #54 1XRNA 0.041
2XRNA 0.095
lmTFP1-mKO2l #92 1XRNA -0.014
2XRNA -0.017
lmTFP1-mKO2l #186 1XRNA -0.009
2XRNA 0.075
lmTFP1-mKO3l 1XRNA 0.039
2XRNA 0.096
lmTFP1-lmKO3 1XRNA 0.042
2XRNA 0.057
Table 3.3: The table shows the FRET ratio change, ∆R/R , measured for the different λN22 tagged
donor and acceptor pairs on addition of 5boxB RNA in the cuevette. 1XRNA depicts equimolar
concentration of RNA, donor and acceptor proteins in the solution. 2XRNA depicts when the con-
centration of RNA was two folds higher than the concentration of the donor and acceptor proteins in
the solution. The∆R/R values are also shown as bar graphs below the tables to show the FRET ratio
change in the presence of RNA (1XRNA or 2XRNA) in comparison to zero RNA in the solution.
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In parallel a small experiment was conducted to see if the currently available λN22 and MS2 phage
systems can be used to study RNA conformational change in vivo.The idea behind this experiment
was to prove the principle of riboswitch action using FRET. RNA sequences used for the experiment
were the λN22 cognate binding site 5boxB RNA, and the MS2 phage binding sites (BS). On either
side of thiM the RNA binding sites were tagged. The 5’UTR of the riboswitch was obtained from
E.coli XL-blue competent cells in the lab via PCR. The cloning was done in pRSETB plasmid and
then the entire construct containing the two specific RNA sequences: boxB and MS2 binding sites,
with the thiM5’UTR in the middle was subcloned into pCDNA3 as shown in figure 3.13. the 5boxB
Figure 3.13: Schematic representation of 5boxB-thiM-MS2phage binding site construct inserted in
pcDNA3
sequence was obtained via PCR using p5boxB-SRP RNA plasmid (obtained from Dr. Jan Ellenberg
lab, EMBL, Heidelberg) as the template. pcDNA3-12XMS2BS plasmid (obtained from Dr. Robert
Singer’s lab, Albert Einstein College of Medicine, USA) was used a template to PCR out 6XMS2BS
sequence.
The respective RNA binding proteins were tagged with the fluorescent proteins as shown in figure
3.14. They are the original plasmids obtained from Dr. Jan Ellenberg’s lab and Dr. Robert Singer’s
lab.
The 5boxB-thiM-MS2BS construct was transfected in HeLa cells and then RNA was isolated from
the transfected cells and semi-quantitative PCR was done to check the expression of the construct in
the cells as shown in the gel picture 3.15.
After obtaining the expression of 5boxB-thiM-MS2 BS in the transfected HeLa cultures, next I tried
to co-transfect HeLa cell culture with pcDNA3-5boxB-thiM-MS2 BS plasmid and either with λN22-
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(a)
(b)
Figure 3.14: Schematic representation of RNA binding peptides tagged with fluorescent proteins. (a):
λN22 tagged with EGFP; (b): MS2-phage coat protein tagged with YFP.
EGFP or MS2 coat protein-YFP. The transfected cells were then imaged under a confocal microscope.
The cells showed a pattern of expression and localization of fluorescent proteins (figure 3.16).
From the captured images it was evident that the λN22-EGFP and MS2 coat protein-YFP did not
transport out of the nucleus of the HeLa cells, as it should since the 5boxB-thiM-MS2 BS construct
has a poly-A tag to it and therefore the riboswitch construct must be transported out of the nucleus into
the cytoplasm. Since there was no visible export of the fluorescently tagged RNA binding proteins
out of the nucleus, it is an indication of the nls present on the RBPs not functioning efficiently in the
HeLa cells which could lead to false results; plus the addition of TPP might not yield a fluorescent
emission change as expected if the tagged-RBPs are not exported into the cytoplasm of the transfected
cells. This lead to the idea of developing an RNA binding and tagging system that is independent of
the nls and can target the RNA in the cytoplasm and monitor its conformational change via a FRET
readout.
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Figure 3.15: Results of the semi-quantitative PCR to check 5boxB-thiM-MS2BS expression in HeLa
cell culture.
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(a) (b)
Figure 3.16: Confocal Images of HeLa cells co-transfected with 5boxB-thiM-MS2bs RNA and λN22-
EGFP (a) or MS2 coat protein-YFP (b)
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Chapter 4
Discussion
The aim of this thesis was to study aptamer induced FRET on binding of fluorescent tagged RBP
in vitro, with a bigger picture of developing a method to label RNA in the cytoplasm via FRET
readout and track their movement in the cell. Work has been done previously to study the spatial and
temporal interaction between RNA and protein in the cytoplasm via FRET [61]. I wanted to work on
RNA tagging in vitro, where FRET is the read out, and thus can be used to monitor the conformation
change in the RNA on binding, e.g. riboswitches undergo a conformational change on binding of a
ligand. I used the λN22 system as the aptamer-RNA binding protein system.
As per our hypothesis, λN22 tagged fluorescent proteins should bind the 5boxB RNA sequence in
solution in the cuevette and once in close proximity on the aptamer, there should occur resonance
energy transfer and a change in fluorescence emission spectra should be observed. This should in-
dicate the binding of the λN22 -fluorescent proteins on the RNA Also, once the RNA is discharged
or degraded the FRET should be reversed. A point to be considered here is that on binding of the
peptide the aptamer might undergo a conformational change. Due to this the tethered fluorescent
proteins might either come in favorable FÖRSTER radius range and orientation for a FRET change,
or might be moved out of the FÖRSTER radius (depending on where they bind), or they might be in
the FÖRSTER radius but their oscillation planes are oriented anti-parallel to each other. Therefore, the
conformation the RNA adopts in solution would influence the resonance energy transfer between the
fluorescent proteins.
The other bacteriophage system that is commonly used for in vivo RNA tagging is the MS2 phage (as
mentioned in the introduction) and has been used successfully in quite a number of studies especially
to study RNA trafficking in yeast. It is a system that was discovered prior to the λN22 and has been
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extensively modified for the purpose. Nevertheless the λN22 was the system of choice due to the
advantages it offered over the MS2 system and has been mentioned in the introduction also. The λN22
is smaller in size than the MS2 coat protein. Since λN22 binds as a monomer, it would offer fewer
obstacles for the other fluorescent RBP to bind on the RNA than MS2 coat protein dimer. Also the
MS2 coat protein binds as a dimer in anti-parallel orientation. Since not only distance, but orientation
of the fluorescent proteins influence resonance energy transfer, MS2 coat protein was not an ideal
choice.
Van Gilst et al. [62] reported that the N protein binds in its unfolded form, i.e. it is unfolded in
solution, and this indicates that on binding its cognate boxB structural changes occur in N protein. It
is estimated that 16 – 18 amino acids of the N-protein form an a-helix structure when N binds boxB
RNA. Austin et al. [39] have shown that this a-helical structure binds within the major groove of the
hairpin structure, as also shown in figure 1.8. These factors point to the flexible nature of λN and the
conformational change it undergoes on binding the boxB RNA.
For the boxB RNA, Su et al. [38] proved that the boxB RNA also undergoes conformational change
on binding of the λN , the loop conformation of boxB is stabilized. After that Xia et al. [63] showed
that on binding of boxB RNA with the N protein there is not just a single structural change. They
show that a continuous re-orientation of base stacking occurs between Tryptophan 18 of the N protein
and A7, A8 and A10 bases of the RNA chain. Their findings indicated that in solution, the RNA-
peptide conformations are inherently dynamic and a single static structure can’t be assigned as a
representative of the RNA-peptide complex.
All these findings indicated that there is no fixed structure of the λN that binds in a fixed groove of
the boxB. In order to observe binding of the λN22 peptides on the boxB RNA and also to observe
a conformational change in the RNA on binding of peptide via FRET, there could not be a single
functional orientation of the tagged fluorescent proteins, as it is not known how the tagged fluorescent
proteins, will be oriented spatially once the λN22 is bound to boxB sequence.
For achieving this orientation advantage, I wanted to generate mKO2-λN22 variants where each differ-
ent variant would offer a different distance and orientation when tethered to the RNA so as to avail the
advantage of angular orientation for FRET efficiency when both the donor and acceptor are tethered
to the RNA. Cloning of such mKO2-λN22 variants required inserting the λN22 peptide sequence in
the middle of the mKO2 protein, and it was important that such insertions did not hinder the folding
of mKO2 leading to the loss of fluorescence. Therefore it was necessary to identify tolerant insertion
sites in mKO2.
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One possible approach to achieve this was to introduce restriction enzyme sites in mKO2 via PCR
and then screen the colonies that encode functional fluorescent proteins. But this can be a very time
consuming and laborious process to check the whole sequence for tolerant sites via PCR. Another
major disadvantage of this approach is that it might introduce undesired mutations in mKO2. The
other approach was to use the random insertion behavior of a transposon and insert restriction enzyme
sites in mKO2.
The commercially available transposon, EZ-Tn5, was used for this purpose as the mechanism of its
action is already known, has been modified to achieve high transposition efficiency and has been suc-
cessfully used in other labs [64]. Therefore, the EZ-Tn5 was used in the lab to insert NotI restriction
enzyme sites in mKO2 by Anselm Geiger. This gave the flexibility to use such mKO2 constructs for
insertion of different codons or protein tags. There were a few disadvantages with this approach, one
was that the screening process for the mKO2 colonies after transposition reaction was extensive as
each and every colony had to be screened to find out the site of insertion, some colonies were lost in
this process. Another disadvantage was that only one restriction enzyme site was inserted in mKO2,
due to which 70 % of the clones screened for λN22 insertion had the sequence inserted in the reverse
orientation. Due to the random behavior of EZ-Tn5, some insertions were in the central a-helical
core of the mKO2 protein. Therefore the constructs had to be screened, the amino acid position
of the insertion determined, and the position in the folded mKO2 protein checked using following
programs:
http://www.rcsb.org/pdb/home/home.do
http://www.pymol.org/
Only those constructs were selected which would avail λN22 for binding to the aptamer, i.e. inserted
in the loop region or the b-barrel. Based on this, mKO2 variants with tolerant insertion sites, were
chosen for this project. Figure 4.1 represents all the insertion tolerant sites obtained for mKO2 with
this method and used in this thesis.
Cartoons with single insertion site as in the appendix figures B. I also wanted to have N- or C-
terminus labeled acceptor proteins to complete the spectra of differently oriented λN22 insertions. As
previously observed in the lab, mKO2 is not tolerant to C-terminal tagging, therefore I used the mKO3
for N- terminus and C-terminus tagging with λN22.
The λN22-inserted mKO2 and mKO3 variants were characterized for their fluorescent properties like
quantum yield and extinction coefficient. This was done in comparison to the mKO2 wild type so
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Figure 4.1: Various insertion sites tolerating in mKO2. See B for detailed figures of each construct.
as to determine their brightness in contrast to mKO2, since a high value of quantum yield, results
in bright fluorescent protein. The fluorescent proteins were designed for use in FRET experiments,
where the rate of energy transfer is influenced by the quantum yields of the donor and acceptor, and
the fluorescent properties which are: absorption spectra, extinction coefficient and emission spectra.
The table 3.1 as well as the graphs 3.6 and 3.7 in section 3.2 show the differences amongst the mKO2
and mKO3-λN22 variants and with regards to the original mKO2 fluorescent protein. The mKO2-λN22
variants #49, 51, 54, 92, 186, mKO3-λN22 and λN22-mKO3 had high values for quantum yield (less
than mKO2 (WT)), compared to the other variants #88 and 90. #49, 54, 186, mKO3-λN22 and λN22-
mKO3 had higher extinction coefficient at 549 nm mKO2 (WT). The extinction coefficient values of
constructs #53, 169 and 188 were very low. Similar results were obtained for absorption spectra where
#53, 88, 90, 169 and 188 fared pretty badly in comparison to the others. Based on these results the
mKO2_l variants #49, 51, 54, 92, 186, mKO3_l and l_mKO3 were selected for FRET experiments
as from these properties it was apparent that these variants would form good acceptors for EGFP and
mTFP1.
The donor proteins EGFP and mTFP1, were λN22 tagged either at the N- or C-terminus. The donor
mTFP1 has been used in the lab for FRET experiments with satisfactory results. The EGFP has also
been used in the lab for previous experiments with satisfactory results. Therefore, the donor proteins
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were considered good choice for FRET experiments.
Considering the above factors, it was reasoned that some of the mKO2 and mKO3 variants could
yield a FRET ratio change when paired with either of the donors, in presence of the aptamer. The
aptamer designed for the project had 5 boxB sites separated by a linker region, as shown in 3.4 on
page 74. As Van Gilst et al. [62] have also shown that the boxB oligomer and λN form a complex with
a stoichiometry 1:1, therefore on a 5boxB sequence at least 3 fluorescently tagged λN should bind
assuming that the fluorescent protein might hinder another tagged λN molecule to bind the adjacent
boxB loops. Rajan Lamichhane et al. have recently shown in their study [65] using steady state
FRET (ssFRET) and time resolved FRET (trFRET) that the spaced length of at least 15 nucleotides is
required for significant FRET read-out. If the spacer length between the RNA loops is 5 nucleotides
or less, no FRET was visible. But in their experiment only 2 RNA loop regions linked by a spacer
were used. In my experiment, 5boxB has a 4 – 6 nucleotides long spacer between the loop regions.
But here as the number of loops is more, the small size of the spacer should not be a problem. Since
the donor, acceptor and the RNA were present in 1:1:1 stoichiometry in the cuevette, hypothetically a
donor and acceptor should bind on the same RNA sequence leading to resonance energy transfer.
As can be seen from the FRET results, there is seen a slight increase in mKO2 emission spectra, on
addition of only mKO2 in the cuevette. This could not be due to excitation of mKO2 by the donor
excitation wavelength, as care was taken to ensure that donor excitation wavelength which does not
cause excitation of mKO2. This emission spectra observed on addition of λN22 tagged fluorescent
proteins could not be due to an interaction between λN - λN peptides, because mKO2 emission was
observed even without λN22 tagging on the fluorescent proteins. This can be seen from the graphs in
figure A.17 and A.18 where mKO2 emission is measured for donor and acceptor pairs where either
both or one of the FRET partners is not λN22 tagged. This indicates an unspecific FRET ratio change
occurring between the fluorescent proteins.
After this clarification, the DR/R values obtained for the FRET measurements (shown in the results
section) on addition on RNA could be only due to a FRET change between the donor (λN22 tagged
EGFP/mTFP1) and the acceptor (λN22 inserted mKO2/mKO3). There is an increase in DR/R values
for some FRET pairs with 2 fold RNA. This increase in FRET ratio from 1-fold to 2-fold RNA
concentration is not a trend observed for all FRET pairs. Even for the same mKO2 construct different
results are seen. However, mKO3-λN22 and λN22-mKO3 have exhibited high values of FRET ratio
change with most donors, whereas, mKO2-λN22 #92 exhibited negative FRET with λN22-mTFP1
and mTFP1-λN22. As a donor λN22-mTFP1 yielded the highest FRET ratio change with most of the
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mKO2-and mKO3-λN22 variants, followed by EGFP-λN22. λN22-EGFP and mTFP1-λN22 yielded
poor FRET ratio changes in comparison.
Since FRET is not only dependent on the distance but also on the favorable orientation dipoles be-
tween the donor and acceptor, it is possible these conditions were not satisfied for many FRET pairs.
The observed difference in DR/R values with 1-fold and 2-fold RNA concentration also points to
the same reason. With increase in the number of RNA molecules, any unbound donor and acceptor
proteins present in the solution are tethered to the RNA, which might or might not be favorable condi-
tions for FRET. The other theory that could be offered is that with increase in RNA molecules in the
solution, a re-arrangement occurs amongst the molecules present in solution and some proteins bind
to the newly available RNA. Due to this re-organization some arrangements offered favorable condi-
tions for FRET while others did not. This could explain why some FRET pairs display an increase in
FRET ratio change while others show a decrease, on increasing the RNA concentration.
Along with FRET ratio change there was also observed a decrease in emission intensity. This decrease
in emission intensity is observed not only for the acceptor emission but also for the donor. As seen
from the result graphs, there is a decrease in emission intensity on addition of equimolar concentration
of RNA. On increasing the concentration of RNA in the cuevette to 2-fold, there is further drop in
the emission intensity for almost all of the FRET pairs. Test was done to check if the emission
intensity of the donor keeps on decreasing with increasing the RNA concentration in the solution.
The FRET read out was taken with the same concentrations and under the same conditions as for the
original experiment. The result of this experiment can be seen from figure 4.2. There is a decrease
in emission intensity of the λN22 tagged donors in the presence of equimolar concentration of RNA.
However, there was no change observed in the absorption spectra of the donors on addition of RNA
as is evident from the graphs in figure 4.3 on page 92.
This decrease in the emission intensity of the donor and the acceptor can be due to fluorescence
quenching. Quenching is a phenomenon where the excited molecules relax to ground state via non-
radiative pathways avoiding fluorescence emission (i.e. vibration, collision, intersystem crossing).
There is also quenching via molecular oxygen and polar solvents such as water. This phenomenon of
quenching was applied by Van Gilst et al. [62] to measure the binding between N protein and boxB.
They observed that the N protein, which carried two Tryptophan residues, shows an appreciable over-
all decrease of fluorescence on binding with boxB. With saturation concentrations of RNA maximum
quenching was observed. Going by this idea, in the current study, maximum quenching was probably
observed on addition of equimolar concentration of RNA. Thus, the quenching might occur due to a
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proximal nucleobase through an outer sphere electron transfer. The rate of quenching depends on the
RNA sequence immediately next to the fluorophore as the quenching depends of the frequency of dif-
fusional encounters of and the activation barrier for redox chemistry between the excited fluorophore
and the base [66]. The role of RNA in decreasing the fluorescence emission of the donor could be the
secondary structure it assumes in the buffer which might cause quenching. In the present study it is
possible that the binding of the λN22 tagged FPs to the boxB, while causing structural re-organization
of boxB and the λN22 , might have brought the FPs in proximity to certain bases that lead to quench-
ing of fluorescence. Unfortunately, the result of RNA binding on only the acceptor emission intensity
was not studied. To properly quantify for the FRET ratio change, it would be necessary to find out
the percentage quenching due to RNA binding (also on increasing the RNA concentration). A useful
experiment would also be to check the binding of the λN22 tagged fluorescent proteins with single
boxB RNA via electromobility shift assay.
With the small experiment to study the conformational change in RNA upon binding to a ligand in
vivo, since no export of fluorescent proteins was observed in HeLa cells co-expressing RNA and RBP
tagged with fluorescent protein, it could be assumed that either the RNA did not bind the RBP or there
was no transport. As can be seen in the results section the RNA was expressed by the cells. Under
such conditions addition of the ligand, Thiamine Pyrophosphate, would not yield a FRET change
even if there is a conformational change in the RNA. This small experiment brought to light some of
the problems associated with dependence on nuclear localization signal for tagging, transport of RNA
and also to study conformational change in RNA. This also specified the importance of a method to
monitor RNA tagging in the cytoplasm, via FRET change, and also for studying RNA dynamics.
In conclusion, an unspecific FRET ratio change, no related to aptamer binding, was observed between
the λN22 tagged EGFP/mTFP1 donor proteins and mKO2/mKO3-λN22 variants. Apart from one vari-
ant, mKO2-λN22 #92, most of the variants have shown FRET ratio change with the donors although it
is not a significant FRET change in some cases. No clear trend could be observed for FRET, even for
the same FRET pairs on increasing the RNA concentration. Another interesting observation was the
quenching of emission intensity which was observed on binding of λN22 tagged fluorescent proteins
on the 5boxB RNA.
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Outlook
This thesis shows an interesting aspect of λN22-boxB binding via FRET. There are a number of future
experiments which should be conducted to answer some questions raised by the results obtained in
this study.
Firstly, it is necessary to quantify the quenching of emission intensity of both the donor and acceptor
proteins, separately and together, on binding of the RNA. The sequence and the structure of the in
vitro transcribed RNA should be studied to help understanding the quenching of emission intensity.
On the same note, the structure of the fluorescent protein tagged λN22, on binding of λN22-boxB,
is important to understand if this quenching is due to proximity of the fluorescent protein with a
nucleobase.
The donors EGFP/mTFP1 should also be generated with λN22 inserted in different tolerant insertion
sites using the EZ-TN5 system. This would provide more orientation flexibility for FRET and for the
choice of a good donor-acceptor pair. But this experiment should be coupled with use of 2 boxB or
3 boxB RNA sequences also. In 2 boxB sequences, the length of the spacer between the loops could
be increased to accommodate both the donor and acceptor on the same sequence. With 2 or 3 boxB
sequences the number of binding sites on the RNA is reduced and this could give a better idea of
distance and flexibility of the spacer affecting FRET.
A better modification to the above experiment would be to use two different bacteriophage systems,
e. g. link MS2 phage binding site with boxB and label MS2 coat protein and λN22 with either of
the two FRET partners. This would decrease the chances of having both sites on the RNA occupied
by either donor or acceptor protein, and would give a clear FRET readout. By varying the spacer
distance between the two RNA loops and using differentially oriented fluorescent proteins (generated
via EZ-Tn5 system) favorable FRET pairs can be designed which would be useful for RNA tagging
and for studies involving conformational change of RNA.
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(a) (b)
(c) (d)
Figure 4.2: Fluorescence emission spectra of EGFP-λN22 (a) and λN22-EGFP (b) with and without
RNA. Excitation was at 465 nm and the emission spectra recorded from 480-650nm. Fluorescence
emission spectra of mTFP1-λN22 (c) and λN22-mTFP1 (d) with and without RNA. The excitation
was at 460 nm and the emission spectra was taken from 470-650 nm. The black curve indicate the
emission spectra of only the λN22 tagged donor protein. Emission spectra of the donor on addition of
equimolar concentration of 5boxB RNA is indicated by red curves, while the blue curves indicate the
emission spectra for the second reading taken after 2 minutes.
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(a) (b)
(c) (d)
Figure 4.3: Graphs showing the absorption spectra of EGFP–λN22 and λN22–EGFP with (a) and
without RNA (b) and absorption spectra of λN22-mTFP1 and mTFP1-λN22 with (c) and without RNA
(d). The black curves indicate the absorption spectra of λN22 tagged EGFP/mTFP1 and the red curves
indicate the absorption spectra in the presence of equimolar concentration of 5boxB RNA.
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Appendix A
Experiment Results
A.1 Result graphs
(a) (b)
Figure A.1: Fluorescence emission spectra for FRET between EGFP-λN22 and mKO2-λN22 #49 (a)
and #51 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of RNA
compared to the molar ratio of proteins in the cuevette. The excitation was at 465 nm and the emission
spectra was taken from 480 nm – 650 nm. The black curves indicate the emission spectra of the λN22
tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted acceptors, the
blue curves for emission in the presence of equimolar concentration of 5boxB RNA and the green
curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.2: Fluorescence emission spectra for FRET between EGFP-λN22 and mKO2-λN22 # 54 (a)
and 92 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of RNA
compared to the molar ratio of proteins in the cuevette. The excitation was at 465 nm and the emission
spectra was taken from 480 nm – 650 nm. The black curves indicate the emission spectra of the λN22
tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted acceptors, the
blue curves for emission in the presence of equimolar concentration of 5boxB RNA and the green
curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.3: Fluorescence emission spectra for FRET between EGFP-λN22 and mKO2-λN22 # 186 (a)
and mKO3-λN22 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio
of RNA compared to the molar ratio of proteins in the cuevette. The excitation was at 465 nm and the
emission spectra was taken from 480 nm – 650 nm. The black curves indicate the emission spectra
of the λN22 tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted
acceptors, the blue curves for emission in the presence of equimolar concentration of 5boxB RNA
and the green curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.4: Fluorescence emission spectra for FRET between EGFP-λN22 and λN22-mKO3 (a) and
between λN22-EGFP and mKO2-λN22 # 49 (b). The measurements were taken without RNA and with
1 and 2 fold molar ratio of RNA compared to the molar ratio of proteins in the cuevette. The excitation
was at 465 nm and the emission spectra was taken from 480 nm – 650 nm. The black curves indicate
the emission spectra of the λN22 tagged donor proteins, the red curves indicate the emission spectra
with λN22 inserted acceptors, the blue curves for emission in the presence of equimolar concentration
of 5boxB RNA and the green curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.5: Fluorescence emission spectra for FRET between λN22-EGFP and mKO2-λN22 #51 (a)
and #54 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of RNA
compared to the molar ratio of proteins in the cuevette. The excitation was at 465 nm and the emission
spectra was taken from 480 nm – 650 nm. The black curves indicate the emission spectra of the λN22
tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted acceptors, the
blue curves for emission in the presence of equimolar concentration of 5boxB RNA and the green
curves for the emission with two fold concentration of 5boxB RNA.
97
(a) (b)
Figure A.6: Fluorescence emission spectra for FRET between λN22-EGFP and mKO2-λN22 # 92 (a)
and # 186 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of RNA
compared to the molar ratio of proteins in the cuevette. The excitation was at 465 nm and the emission
spectra was taken from 480 nm – 650 nm. The black curves indicate the emission spectra of the λN22
tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted acceptors, the
blue curves for emission in the presence of equimolar concentration of 5boxB RNA and the green
curves for the emission with two fold concentration of 5boxB RNA.
98
(a) (b)
Figure A.7: Fluorescence emission spectra for FRET between λN22-EGFP and mKO3-λN22 (a) and
λN22-mKO3 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of
RNA compared to the molar ratio of proteins in the cuevette. The excitation was at 465 nm and the
emission spectra was taken from 480 nm – 650 nm. The black curves indicate the emission spectra
of the λN22 tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted
acceptors, the blue curves for emission in the presence of equimolar concentration of 5boxB RNA
and the green curves for the emission with two fold concentration of 5boxB RNA.
(a) (b)
Figure A.8: Normalized fluorescence emission spectra for FRET of EGFP-λN22 (a) and λN22-EGFP
(b) with the various mKO2 and mKO3 variants. The spectra were normalized at 508 nm.
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(a) (b)
Figure A.9: Fluorescence emission spectra for FRET between mTFP1-λN22 and mKO2-λN22 # 49 (a)
and # 51 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of RNA
compared to the molar ratio of proteins in the cuevette. The excitation was at 458 nm and the emission
spectra was taken from 470 nm – 650 nm. The black curves indicate the emission spectra of the λN22
tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted acceptors, the
blue curves for emission in the presence of equimolar concentration of 5boxB RNA and the green
curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.10: Fluorescence emission spectra for FRET between mTFP1-λN22 and mKO2-λN22 # 54
(a) and # 92 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio of
RNA compared to the molar ratio of proteins in the cuevette. The excitation was at 458 nm and the
emission spectra was taken from 470 nm – 650 nm. The black curves indicate the emission spectra
of the λN22 tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted
acceptors, the blue curves for emission in the presence of equimolar concentration of 5boxB RNA
and the green curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.11: Fluorescence emission spectra for FRET between mTFP1-λN22 and mKO2-λN22 # 186
(a) and mKO3-λN22 (b). The measurements were taken without RNA and with 1 and 2 fold molar
ratio of RNA compared to the molar ratio of proteins in the cuevette. The excitation was at 458 nm
and the emission spectra was taken from 470 nm – 650 nm. The black curves indicate the emission
spectra of the λN22 tagged donor proteins, the red curves indicate the emission spectra with λN22
inserted acceptors, the blue curves for emission in the presence of equimolar concentration of 5boxB
RNA and the green curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.12: Fluorescence emission spectra for FRET between mTFP1-λN22 and λN22-mKO3 (a)
and between λN22-mTFP1 and mKO2-λN22 # 49 (b). The measurements were taken without RNA
and with 1 and 2 fold molar ratio of RNA compared to the molar ratio of proteins in the cuevette. The
excitation was at 458 nm and the emission spectra was taken from 470 nm – 650 nm. The black curves
indicate the emission spectra of the λN22 tagged donor proteins, the red curves indicate the emission
spectra with λN22 inserted acceptors, the blue curves for emission in the presence of equimolar con-
centration of 5boxB RNA and the green curves for the emission with two fold concentration of 5boxB
RNA.
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(a) (b)
Figure A.13: Fluorescence emission spectra for FRET between λN22-mTFP1 and mKO2-λN22 # 51
(a) and mKO2-λN22 # 54 (b). The measurements were taken without RNA and with 1 and 2 fold
molar ratio of RNA compared to the molar ratio of proteins in the cuevette. The excitation was at
458 nm and the emission spectra was taken from 470 nm – 650 nm. The black curves indicate the
emission spectra of the λN22 tagged donor proteins, the red curves indicate the emission spectra with
λN22 inserted acceptors, the blue curves for emission in the presence of equimolar concentration of
5boxB RNA and the green curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.14: Fluorescence emission spectra for FRET between λN22-mTFP1 and mKO2-λN22 # 92
(a) and mKO2-λN22 # 186 (b). The measurements were taken without RNA and with 1 and 2 fold
molar ratio of RNA compared to the molar ratio of proteins in the cuevette. The excitation was at
458 nm and the emission spectra was taken from 470 nm – 650 nm. The black curves indicate the
emission spectra of the λN22 tagged donor proteins, the red curves indicate the emission spectra with
λN22 inserted acceptors, the blue curves for emission in the presence of equimolar concentration of
5boxB RNA and the green curves for the emission with two fold concentration of 5boxB RNA.
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(a) (b)
Figure A.15: Fluorescence emission spectra for FRET between λN22-mTFP1 and mKO3-λN22 (a)
and λN22-mKO3 (b). The measurements were taken without RNA and with 1 and 2 fold molar ratio
of RNA compared to the molar ratio of proteins in the cuevette. The excitation was at 458 nm and the
emission spectra was taken from 470 nm – 650 nm. The black curves indicate the emission spectra
of the λN22 tagged donor proteins, the red curves indicate the emission spectra with λN22 inserted
acceptors, the blue curves for emission in the presence of equimolar concentration of 5boxB RNA
and the green curves for the emission with two fold concentration of 5boxB RNA.
(a) (b)
Figure A.16: Normalized fluorescence emission spectra for FRET of mTFP1-λN22 (a) and λN22-
mTFP1 (b) with the various mKO2 and mKO3 variants. The spectra were normalized at 490 nm.
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A.2 Discussion graphs
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(a) (b)
(c)
Figure A.17: Emission spectra measured for donor and acceptor pairs where either both or one of the
FRET partners is not λN22 tagged, in absence of RNA. Excitation was at 465 nm ,where EGFP is the
donor, and the emission spectra was taken from 480 nm – 650 nm. Excitation was at 458 nm, where
mTFP1 is the donor, and the emission spectra was taken from 470 nm – 650 nm. The black curves
indicate the emission spectra for the donor protein (with or without λN22 ) and the red curves indicate
the emission spectra in the presence of the acceptor protein (with or without λN22).
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(a) (b)
Figure A.18: Emission spectra measured for donor and acceptor pairs where either both or one of the
FRET partners is not λN22 tagged, in absence of RNA. Excitation was at 465 nm ,where EGFP is the
donor, and the emission spectra was taken from 480 nm – 650 nm. Excitation was at 458 nm, where
mTFP1 is the donor, and the emission spectra was taken from 470 nm – 650 nm. The black curves
indicate the emission spectra for the donor protein (with or without λN22 ) and the red curves indicate
the emission spectra in the presence of the acceptor protein (with or without λN22).
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Appendix B
Various tolerant insertion sites in mKO2
(a) # 49 (b) # 51 (c) # 53
Figure B.1: Various tolerant insertion sites of mKO2 used in this thesis for λN22 insertion.
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(a) # 54 (b) # 88 (c) # 90 (d) # 92
(e) # 169 (f) # 186 (g) # 188
Figure B.2: Various tolerant insertion sites of mKO2 used in this thesis for λN22 insertion (continua-
tion).
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Figure B.3: Different docking orientation of mKO2-λN22 variants on boxB loop.
In black is depicted the boxB loop structure, blue is the λN22 tagged donor protein, differentially
oriented mKO2 fluorescent proteins are depicted in red.
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